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ABSTRACT OF THE DISSERTATION
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by
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Florida International University, 2017
Miami, Florida
Professor Bernard S. Gerstman, Co-Major Professor
Professor Prem P. Chapagain, Co-Major Professor
Multifunctional proteins that undergo major structural changes to perform
different functions are known as “Transformer Proteins”, which is a recently identified
class of proteins. One such protein that shows a remarkable structural plasticity and has
two distinct functions is the transcription antiterminator, RfaH. Depending on the
interactions between its N-terminal domain and its C-terminal domain, the RfaH CTD
exists as either an all-α-helix bundle or all-β-barrel structure. Another example of a
transformer protein is the Ebola virus protein VP40 (eVP40), which exists in different
conformations and oligomeric states (dimer, hexamer, and octamer), depending on the
required function.
I performed Molecular Dynamics (MD) computations to investigate the structural
conversion of RfaH-CTD from its all-a to all-b form. I used various structural and
statistical mechanics tools to identify important residues involved in controlling the
conformational changes. In the full-length RfaH, the interdomain interactions were found
to present the major barrier in the structural conversion of RfaH-CTD from all-a to all-b
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form. I mapped the energy landscape for the conformational changes by calculating the
potential of mean force using the Adaptive Biasing Force and Jarzynski Equality
methods. Similarly, the interdomain salt-bridges in the eVP40 protomer were found to
play a critical role in domain association and plasma membrane (PM) assembly. This
molecular dynamic simulation study is supported by virus like particle budding assays
investigated by using live cell imaging that highlighted the important role of these
saltbridges. I also investigated the plasma membrane association of the eVP40 dimer in
various PM compositions and found that the eVP40 dimer readily associates with the PM
containing POPS and PIP2 lipids. Also, the CTD helices were observed to be important in
stabilizing the dimer-membrane complex. Coarse-grained MD simulations of the eVP40
hexamer and PM system revealed that the hexamer enhances the PIP2 lipid clustering at
the lower leaflet of the PM. These results provide insight on the critical steps in the Ebola
virus life cycle.
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1. INTRODUCTION
1.1 Transformer proteins
Proteins are molecular machines that provide the high physical organization and
low entropy required for life. Proteins perform a myriad of biophysical tasks in cells such
as molecular transportation, enzymatic activities, energy transfer, and signaling. In order
to perform their physiological functions, most proteins have to fold to their corresponding
native state structures, which are highly specific three-dimensional conformations (1).
Depending on the biochemical environment, some proteins are observed to have multiple
functions. A protein that exhibits multiple functions is categorized as an interesting
subset of moonlighting proteins (2). In performing alternate functions, a moonlighting
protein can utilize different protein interfaces (3) of the same configuration. However, a
recent development has added a new twist to the relationship between protein structure
and function.
Protein conformational dynamics in the functional state includes local, small-scale
flexibility observed in sidechains, loops, or at a binding site, as well as larger, global
conformational rearrangements such as domain separation or oligomerization (4).
Intrinsically unstructured proteins may have sufficient structural flexibility to interact
with multiple partners, whereas globular proteins can undergo structural changes (5) that
allow them to perform different functions. Globular proteins such as lymphotactin (6) and
Mad2 (7) undergo small structural rearrangements that lead to different functions and are
referred to as metamorphic proteins (8).
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Recently, a new class of multifunctional proteins has been identified as
“transformer proteins” (9). Transformer proteins show a remarkable ability to rearrange
their structure to significantly different conformations that perform completely different
functions. An example of such a protein is the transcription antiterminator RfaH.
Depending on the interactions between its N-terminal domain (10) and its C-terminal
domain (10), the CTD of RfaH exists as either an all-α-helix bundle or all-β-barrel
structure. The RfaH-CTD in the all-α topology is involved in regulating transcription,
whereas in the all-β topology it is involved in stimulating translation by recruiting a
ribosome to an mRNA (11). Another example of a transformer protein is the Ebola virus
protein VP40, which exists in different conformations depending on the required
function: a butterfly shaped dimer is involved in the transport of the protein to a
membrane, a hexamer to form the viral matrix, and an octamer ring structure to bind to
RNA and regulate viral transcription (12).
I performed Molecular Dynamics (13) computations to investigate the dynamic
behavior of transformer proteins RfaH and Ebola virus protein VP40 and identified the
interaction mechanisms and pathways of conformational changes in these proteins. The
large scale structural changes in RfaH-CTD were observed using various enhanced
sampling simulation methods as described in Chapter 2. The MD studies performed on
RfaH and the Ebola virus protein VP40 highlighted the important salt-bridges that play
crucial roles in domain-domain association. My research also involves the study of the
interactions between the protein and a membrane. I investigated the association of the
VP40 dimer with the plasma membrane using all-atom molecular dynamics simulations
as well as coarse-grained simulations. Through all-atom simulations, I have investigated
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the mechanisms of plasma membrane localizations of VP40 and identified residues that
are important for stabilizing the VP40 dimer at the lower leaflet of the plasma membrane.
The coarse grained simulations allowed me to investigate the dynamics of lipids and
proteins for the larger hexamer-membrane system for much longer time-scales. This
study revealed an enhanced clustering of a specific lipid type (14) in the lower leaflet of
the plasma membrane in the presence of a VP40 hexamer.

1.1.1 RfaH Transcription Factor
I studied the RfaH protein because it is one of the smaller proteins that exhibit
transformer properties. A recent study (11) on the two-domain transcription factor RfaH
revealed that its function is very different depending on whether its CTD is in an α-helix
or β-sheet conformation (15). Magnetic resonance (13) measurements revealed that the
C-terminal domain (CTD) of the transcription anti-terminator RfaH (PDB-ID: 2OUG)
exists as an α-helix bundle when it interacts with the N-terminal domain (NTD) of the
same protein, but folds to a five-stranded all-β conformation (PDB-ID: 2LCL) when it is
not interacting with the NTD. These two structures are shown in figure 1.1. The RfaH
protein conformation is closely related to another two-domain transcription factor
NusG(16). Although the NTD conformations of both RfaH and NusG are similar, the
CTD conformations differ significantly. Unlike the CTD of RafH that has an all-α native
fold when it interacts with its NTD, the CTD of NusG (PDB-ID: 2JVV) has an all-β fold.
The similar NTD conformations of both RfaH and NusG have identical roles in RNA
Polymerase (RNAP) binding. However, the existence of two different conformations of
RfaH-CTD allows an additional function for this domain. The RfaH-CTD in the all-α
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topology is involved in transcription regulation by masking the RNAP binding site in the
absence of a DNA recruitment signal, whereas in the all-β topology it is involved in
stimulating translation by recruiting a ribosome to an mRNA that lacks a ribosomebinding site. Just as in NusG, binding of RfaH to the RNAP and protein S10 occurs when
the CTD is in its β-form, which requires breaking of the NTD and CTD contacts. The
domain separation is believed to be triggered by RfaH interactions with an ops element
(17), (18) which then leads to spontaneous refolding of the CTD into the β-barrel.
Figure 1.1 shows the structural conversion of the RfaH-CTD. The N-terminal domain
(NTD) is colored in green and the C-terminal domain (CTD) is colored in yellow.

Figure 1.1 Structural conversion of RfaH-CTD. The N-terminal domain (NTD) is colored
in green and C-terminal domain (CTD) is colored in yellow.
The conformational transformations in RfaH-CTD that allow it to perform
different functions places it in the category of a transformer protein (TFP) (19), a class
which may eventually include many other functional proteins yet to be identified. The
details of the folding mechanism and structural transitions in RfaH are of great interest. It
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has recently been shown (13) that after denaturation, the inter-domain contacts with the
NTD are sufficient to fold the CTD into the α-helical form from the denatured state.
Further, when only the CTD is expressed, it folds completely to a β-barrel structure.
Interestingly, when the domains are swapped to reverse the order of NTD and CTD
translation, functional activity of the α-helical form is still observed in-vitro, but with the
observed activity being significantly reduced, suggesting the possibility that a fraction of
chains formed β-structure(13).
The a-helix to β-sheet structural transition in the CTD of RfaH is an example of a
biophysical process that is frequently observed in the aggregation and fibrilization of
amyloidogenic proteins. Such protein structural transitions are thought to be critical
processes in the development of a variety of neurodegenerative diseases such as
Alzheimer’s, Parkinson, Huntington, and prion diseases, which are considered to be the
result of protein misfolding (20). The amyloid fibrils that are implicated in these diseases
are composed of proteins that transform from innocuous, soluble configurations such as
α-helices, into β-strands that aggregate into sheets (21), (22). A well studied example
(23), (24) is the structural conversion of the native α-helical form of the prion protein
PrPC into the pathogenic β-sheet-rich form PrPSc that causes transmissible spongiform
encephalopathy (scrapie). Recent investigations have shown that the α-to-β conversion in
PrP can occur even in the absence of the infectious molecular species (25). This α-to-β
conversion also holds true for the structural transitions of the amyloid beta (Aβ) precursor
peptide system, which is responsible for amyloid deposits in Alzheimer’s disease (26).
Although such peptides can undergo structural transitions, the presence of an oligomer
seed can accelerate the oligomerization and fibril formation processes (27), (28). Another

5

example of spontaneous structural conversion occurs in a group of cc-beta peptides,
which form coiled-coil helical structures at low temperatures but convert to β-sheet rich
amyloid fibrils at elevated temperatures (29), (30). In addition to the role played in many
neurological disorders (31), the α-helix to β-sheet transition in amyloidogenic peptides is
of great interest for the engineering of novel biomaterials from synthetic peptides (32).

1.1.2 Ebola virus protein VP40
The Ebola virus is a lipid-enveloped virus that causes hemorrhagic fever with a
high mortality rate. The virus uses its negative sense RNA genome to replicate its seven
genes in the host cell. To overcome the limitations posed by its small genome, the Ebola
virus utilizes proteins with astonishing abilities to change structures and perform multiple
functions (33). The Ebola virus protein VP40 shows remarkable conformational plasticity
in forming various oligomeric structures that perform different functions and therefore is
a transformer protein. The Ebola virus protein VP40 consists of an N-terminal domain
(NTD) that is involved in dimerization and a C-terminal domain (CTD) that mediates
membrane binding and oligomerization (12). It exists in various conformations
depending on the required function: a butterfly shaped dimer is involved in the transport
of the protein to a membrane, a hexamer to form the viral matrix, and an octamer ring
structure to bind to RNA and regulate viral transcription (12). As with other recently
identified transformer proteins such as the RfaH transcription factor (11), (13), (34) the
structural basis and mechanisms of large-scale structural transformation in VP40 are not
well understood.
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The Ebola virus protein VP40 is a peripheral protein that localizes in the inner
leaflet of the plasma membrane (PM) (35) and forms the viral matrix which provides the
major structure for the virus-like particles (VLP). Formation of the matrix from the
assembly and oligomerization of VP40 dimers involves a series of steps. First, a VP40
dimer is trafficked to the plasma membrane where electrostatic interactions occur
between the anionic lipids and the basic patch of the VP40 C-terminal domain (CTD).
This electrostatic interactions was determined with experiments in which deletion of
several lysine residues in CTD loops prevented VLP formation, even though the dimeric
structure was unaltered. Once at the plasma membrane, it has been hypothesized that the
VP40 dimers undergo major structural rearrangements and oligomerize into hexameric
structures (12), (36) which oligomerize to form filaments that associate further to form
the viral matrix (37). Although the x-ray crystal structures of the dimeric and hexameric
forms provide information about structural transformations that must occur, the
mechanisms of VP40-membrane interactions leading to the structural transformations
from dimers to hexamers and hexamers to larger filamentous structure are not well
known.
Figure 1.2 presents the structures of the VP40 dimer, hexamer and octamer.
Because of its low molecular weight, the dimer is trafficked to the lower leaflet of the
plasma membrane, whereas the hexamer is the major structural oligomer and the octamer
binds RNA to control transcription.
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Figure 1.2 Different Structures of VP40.
1.2 Molecular Dynamics computer simulation
Most of the work reported here used molecular dynamics (MD) (13) computer
simulations to uncover molecular biophysics principles concerning the structural
transformations. The MD method evolved from theoretical physics in the late 1950s and
is now used in a variety of fields, including drug discovery (38). The MD computer
simulations use basic laws of physics. A biomolecule such as a protein is treated as a long
polymer chain consisting of many atoms that are represented as classical particles. The
forces between interacting atoms and the overall energy of the system is calculated by a
force field. The equation below represents the overall energy of the system.
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∑ K (r − r ) + ∑ K (θ − θ )

U total =

b

0

bonds

+

θ

2

0

angles

+

∑

Kϕ ⎡⎣1+ cos ( nϕ − ϕ 0 )⎤⎦

dihedrals

⎛A B ⎞
qi q j
⎜⎜ 12ij − 6ij ⎟⎟ + ∑
rij ⎠ electrostatic ε rij
van der Waals ⎝ rij

∑

i, j pairs

i, j pairs

(1.2.1)

Figure 1.3 below shows various interactions used in MD simulations. A chemical bond
between two adjacent atoms is modeled as a virtual spring with a harmonic potential. The
angular term measures the energy from the angles between each pair of covalent bonds
sharing the same atom at the vertex. A dihedral term describes a torsional angle φ of a
central bond connected to two covalent bonds. For the four covalently bonded atoms
i,j,k,l, the torsional angle is the angle between plane i,j,k and j,k,l. This interaction is also
periodic in nature. The geometry or chirality of four planar covalently bonded atoms can
defined by “improper terms” that can be added to eq. (1.2.1), and are also harmonic in
nature. The non-bonded interaction consists of Van der Waal’s forces defined by Lenard
Jones 6-12 potentials and the pairwise electrostatic interaction given by Coulomb’s Law
with the screening constant ε. For a system of N atoms there are N2/2 non-bonded
distinct atom pairs, with most of the computation time in MD used in calculating these
interactions. Therefore these interactions are truncated using switching function in MD
simulations that smoothly cutoff the non-bonded interactions at user chosen cutoff
distances. Typically, non-bonded interactions between atom pairs beyond a cutoff
distance of 12Å are set to zero.
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Figure 1.3 Illustration of all bonded terms of potential energy used in MD
The initial position of a biomolecule is assigned from the x-ray crystallographic
structure, NMR or homology modelling. The initial velocity is assigned using Maxwell
Boltzmann distribution of velocities at certain temperature T. Then the force is calculated
using the gradient of potential energy function. The position and velocities are updated in
a short time step and are saved. The position and velocity of each atom at each time step
is the information contained in a file called the MD trajectory. The MD trajectory is post
processed using concepts of statistical physics to calculate a variety of thermodynamic
and kinetic properties to understand the dynamics of complex biomolecules, which can
be compared with the experimental observables.
The MD time steps are on the order of a femtosecond, but the large scale
structural changes in biomolecules occurs in time scales from millisecond, seconds, or
hours. Conventional MD is unfeasible to apply for these long time scales because of
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computer limitations. Enhanced sampling simulation methods like Steered MD, Targeted
MD, Coarse Grained MD etc. close this gap by using statistical physics algorithms. Also,
the use of GPUs has significantly accelerated the MD. The current study employed most
of these techniques to study protein folding, large structural transformations, and
membrane protein interactions.
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2. METHODS
2.1 Replica Exchange Molecular Dynamics (REMD)
In order to explore the protein configurational space, I performed replica
exchange molecular dynamics (REMD) (39) simulations using the MMTSB toolset (40).
To overcome the multiple minima problem, REMD is considered as an efficient and
powerful sampling technique. In the REMD method, a number of replicas of the system,
each at a different temperature, are simultaneously simulated independently for a certain
number of time steps, t. After t time steps, a pair of replicas i and j at different
temperatures, Ti and Tj, that have evolved into different conformations are tested for a
temperature swap. The probability for temperature swapping is given by a Metropolis
type criterion. In this criterion, the probability of exchange is given by 𝑃"# =
min 1, exp −∆ , where ∆= 𝐸# − 𝐸" × 1 𝑘𝑇" − 1 𝑘𝑇# and Ei is the potential energy
of the replica i. The swapping criterion satisfies the condition of detailed balance and
conformations generated at each temperature are a Boltzmann distributed canonical
ensemble. As a result of this swapping, a random walk in temperature space is performed
for each replica, which enhances the replica’s ability to explore the protein’s
configuration space. During stages when its temperature is high, it is more easily able to
exit from configurational kinetic traps and globally sample configuration space, and when
its temperature is low a replica can explore the details of the local region of configuration
space. Although the time sequence of configurations for any replica is not realistic
because of periodic changes in temperature and information on kinetics is lost, the
simulations contain information that can be used in calculations of various
thermodynamic quantities.
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Before commencing the replica exchange procedure, I started the MD simulation
of the α-helix bundle of RfaH-CTD by performing 20 ps of equilibration with a time step
of 2 fs. The system was confined by a spherical quartic potential with a radius of 60 Å,
which is large enough to accommodate fully extended helices. I then created 16 replicas
with exponentially spaced temperatures between 300 and 500 K. A 50-ns production run
was obtained using the implicit solvent EEF1 force field and a 2 fs integration time step,
with a replica swap attempted every 500 steps (1 ps). The atomic dynamics were
propagated via the Langevin method with a reduced friction coefficient of 1 ps-1. The
trajectories for each replica were used to calculate the root-mean-square deviation (rmsd)
from the initial PDB structure, the radius of gyration (rgyr), as well as the number of
hydrogen bonds. VMD (41) was used to visualize and further analyze the trajectories.
The configurational trajectories of all 16 replicas were examined and the structure
closest to the experimentally reported all-β CTD configuration was extracted from one of
the replicas and was relaxed for 50 ns using explicit solvent all-atom MD simulations.
This detailed, explicit solvent all-atom simulation was performed with the NAMD
molecular dynamics package (42) using the CHARMM27 force field (43). The structure
was solvated with the TIP3P water model by using the solvate plugin in VMD. With a
box cut-off of 10 Å away from the protein, the dimensions of the simulation box were 51
x 45 x 43 Å3. The solvated system was electrically neutral. The final system contained a
total of 10,246 atoms. The particle mesh Ewald method (44) was used to treat long range
interactions with a 12 Å non-bonded cutoff. Energy minimization was performed using
the conjugate gradient and line search algorithm. The system was then heated with a
linear gradient of 20 K/ps from 20K to 300K. At 300 K, the system was equilibrated for

13

10 ps, followed by a 50-ns production run with a 2 fs integration time step in the NVT
(constant number, volume, and temperature) ensemble. Langevin dynamics with a
damping constant of 1 ps-1 was used to maintain the temperature at 300 K.

2.2 Steered Molecular Dynamics Simulations (SMD)
In order to explore the all-a to all-b transformation of the CTD in the full RfaH, I
performed Steered Molecular Dynamics (SMD) simulations (45), (42) in explicit water.
The full RfaH was solvated with TIP3P water in rectangular boxes. Pulling
occurred along the x-axis. A cut-off of 10 Å was used for the y- and z-directions, whereas
a large padding was added in the x-direction to allow enough space for protein extension
3

due to pulling. The resulting box dimensions were 198×56×81 Å with a total of 85,567
atoms. The system was neutralized by adding two chloride ions. The particle mesh Ewald
method was used to treat the long-range interactions with a 12 Å non-bonded cut-off.
Simulations were performed with the CHARMM27 force field using NAMD.
For SMD, the dummy atom attached to the C-terminal Cα SMD atom (residue
L162) via a virtual spring (k=3 kcal/mol/Å2) was pulled in the negative x-direction with a
constant speed of 2 Å/ns while keeping the Cα atom of the N-terminal residue (M1) fixed.
SMD was performed with a 1 fs time step and the steering forces were saved every 1 ps.
Trajectories were obtained by alternating pulling and relaxation, i.e., 10 ns of SMD
followed by 10 ns of relaxation. During relaxation, the extension was preserved by
keeping the first Cα in the NTD and the final SMD Cα in the CTD fixed (i.e., setting the
velocity of each to zero), but the protein’s internal structure was allowed to relax after the
forced stretching (46), (47). The average work done by pulling was calculated using nine
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independent simulations, and the potential of mean force (PMF) was calculated using the
Jarzynski equality (48), using an ensemble average of the nine SMD trajectories.
Although PMF calculations with ABF have been shown to represent the reaction more
accurately than with constant velocity SMD (49), the SMD simulations give important
insights into the barriers along the pulling reaction coordinates.
Steered molecular dynamics (SMD) simulations were also performed on Ebola
virus protein VP40 protomer by pulling on the center-of-mass of the CTD (residues 202326) along the negative x-axis. The system consisted of 61,320 atoms in a box of size
117´84´66Å3. All Cα atoms were harmonically restrained during heating and
equilibration. The dummy atom attached to the center-of-mass of the CTD via a virtual
spring (k=3 kcal/(mol/ Å2)) was pulled at a constant speed of 2 Å/ns with respect to the
harmonically restrained NTD (residues 44-194).

2.3 Targeted Molecular Dynamics Simulations (TMD)
In order to further understand the all-a to all-b transformation of the CTD in the
full RfaH, I performed Targeted Molecular Dynamics (TMD) simulations in explicit
water. Targeted MD is especially useful for investigating conformational changes or large
molecular motions that are otherwise unfeasible to access in reasonable computational
times. Targeted MD method has been extensively used in various molecular systems that
undergo large-scale conformational changes that are relevant to protein function. For
example, Targeted MD was used to elucidate the ATP binding mechanism, and to
determine the transition pathways between the open and closed states of GroEL (50).
Similarly, Targeted MD has been used to investigate transitions between open and closed
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states of ion channels and their gating mechanisms in various systems such as a nicotinic
receptor (51), KcsA potassium channels (52), (53), mechanosensitive channels (54), and
the AMPA receptor (55). More relevant to the transitions in RfaH, the dynamical
transition between two distinct states in the Mad2 metamorphic protein was recently
studied using a combination of conventional and Targeted MD and the structural
characteristics as well as dynamic transition mechanisms were explored (56).
The full RfaH with the helical CTD conformation was solvated with TIP3P water
and the system was electrically neutralized by adding counter ions using VMD (41). The
resulting dimensions of the simulation box were 56×54×78 Å3 and the final system
contained a total of 24,082 atoms. The MD simulations were performed with the
CHARMM36 (57) force-field using NAMD (42). The particle mesh Ewald method (44)
was used to treat the long-range interactions with a 12 Å non-bonded cut-off. Energy
minimization was performed using the conjugate gradient and line search algorithm for 5
ps. The system was then heated with a linear gradient of 20 K/ps from 20 to 300 K. At
300 K, each system was equilibrated with a 2 ns NPT run using a 1 fs integration time
step, followed by a 5 ns NVT run also using a 1 fs integration time step. Langevin
dynamics with a damping constant of 1 ps-1 was used to maintain the temperature at 300
K. The RATTLE algorithm was used to constrain protein bonds involving hydrogen.
SETTLE was used to maintain water geometry. Multiple time-stepping algorithms (1-24) were used to compute interactions between atoms. Interactions through covalent
bonds were calculated at every time step, short range non-bonded interactions were
calculated every other step, and long range electrostatic forces at every fourth step.
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A 10 ns equilibration run was performed before commencing each targeted MD
simulation. The target RfaH structure with the beta conformation of CTD was created
using Modeller by connecting the RfaH-NTD and the β-CTD (PDB ID: 2LCL) with a
linker. For a à β conversion, force was applied only on the N=777 heavy (non
hydrogen) atoms of the helical CTD (residues 115-162). For β à a conversion, force was
applied on N=1322 heavy atoms which include all of the CTD (residues 115-162) as well
as an additional 30 residues of NTD that participate in interdomain interaction. The
targeted MD calculation uses the potential energy function 𝑈 =

5
67

[𝑟𝑚𝑠𝑑 𝑡 −

𝑅𝑀𝑆𝐷(𝑡)]6 , where rmsd(t) is the root mean squared deviation (rmsd) of the simulated
structure with respect to the target structure and RMSD(t) is the assigned, target rmsd,
which decrease linearly over time. A force constant per atom of katom=k/N=0.4
kcal/mol/Å2 was used for all TMD simulations.

2.4 Coarse Grained Molecular Dynamics Simulations (CGMD)
To understand the roles of various phospholipids on VP40 hexamer binding in the
PM, I performed coarse-grained molecular dynamics simulations (CGMD) on the
hexamer-membrane system. While all-atom simulations are useful in understanding the
temporal and spatial evolution of a system in the nanosecond timescales, they are
computationally demanding for investigating physical properties such as lipid diffusion
and clustering and protein-membrane interactions that occur on microsecond timescales.
The CGMD (58), (59), (60), (61) model, which maps four heavy atoms on average to a
single interactions site, provides an excellent alternative. The CGMD model simplifies
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the complex energy landscape and enhances the kinetics of the system (61) and has been
extensively used in recent investigations on membrane protein and lipid systems (62),
(63), (64), (65). In one study (66), coarse-grained simulations were found to better
represent the protein-membrane binding as compared to other extended-lipid proteinmembrane models (67). The CG simulations of the highly asymmetric plasma membrane
showed the clustering of the Glycolipids GM3 in the outer leaflet and PI(4,5)P2 in the
inner leaflet. The different types of lipid clustering affect the membrane bending
differently and the correlation of such lipid clustering with the membrane curvature has
important biological implications (68). For example, Basu et al. investigated the
clustering of GM1 with or without PSM using CGMD (69). It was found that in the
presence of PSM, the GM1 domains formed loosely bound clusters, whereas in the
absence of PSM, they were more strongly bound in the clusters. Similarly, Koldso et al.
showed that local enrichment of PI(4,5)P2 in the inner leaflet can induce concave
curvature (viewed from intracellular side) to the plasma membrane (68). This
computaional result is directly relevant to our present work because such a membrane
curvature is needed for the budding of the Ebola virus particle.
For CG simulations, I used the Martini force field in which approximately four
heavy atoms are mapped onto a single interaction site (bead), except for the residues with
aromatic side chains (59). Specifically, Ala and Gly residues are each represented by a
single bead; Cys, Asn, Asp, Gln, Glu, Ile, Leu, Met, Pro, Ser, Thr, and Val are each
represented by two beads; Arg and Lys are each represented by three beads; His, Phe, and
Tyr are each represented by four beads, and Trp is represented by five beads. Similarly
for lipids POPC, POPE and POPS each have 12 beads, PIP2 (70) has 16 beads, PSM has
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11 beads, and CHOL has 8 CG beads. These beads are divided into four interaction types:
Polar (P), nonpolar (N), apolar (C), and charged (Q). There are subtypes d (donor in Hbond), a (acceptor in H-bond), n (none), da (both) and P1 (lower polarity)-P5 (highest
polarity) (59).
The Martini Maker plugin (71) in the Charmm-Gui webserver was used to
prepare both the protein-membrane and membrane-only systems. The Martini 2.0 force
field was used for lipids with a non-polarizable water model, combined with the elastic
network model for the protein (VP40 hexamer). All systems were equilibrated using the
six-step equilibration process generated by the Charmm-Gui (72). Each system was
solvated using standard MARTINI water beads and was neutralized in 0.15 M NaCl. The
final protein-membrane system consisted of 52, 827 particles and the membrane-only
system consisted of 27, 512 beads. The number of lipids used for the CGMD simulations
is given in Table S1 (14). For one of the simulation setups, the elastic network constraints
were removed for all the atoms in the top two CTDs in the middle by setting the spring
constant to zero. Various simulations performed in this work are summarized in Table S2
(14).
All CGMD simulations were run using Gromacs5.1.1 (73), (74) (gpu-version). A
time step of 15 fs was used and the Lennard-Jones and coulomb potential were cutoff at
11 Å. The Verlet neighbor scheme was used with a straight cutoff to keep track of
particles within specified distances (75). Coulomb interactions were treated using a
reaction-field. Ring systems and stiff bonds were controlled using the LINCS algorithm.
The pressure was maintained at 1 bar using the Berendsen barostat during equilibration
runs and the Parrinello-Rahman barostat during production runs. Pressure coupling
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between protein and membrane groups was semi-isotropic with a compressibility of
3x10-4 bar-1. The temperature was maintained at 303.15 K and the temperature coupling
was done using a velocity rescale algorithm.

2.5 Accelerated MD (aMD)
Accelerated molecular dynamics (aMD) simulation is an enhanced sampling
method that adds a non-negative boost potential and can accelerate transitions between
the low energy states (76), (77). This aMD method is superior to other because they
donot require prior knowledge of reaction coordinates. The aMD has been successfully
applied various biomoelcules such as folding of Trp-cage, villin headpiece, WW domain
and chignolin (78). The equations below defines general idea of the aMD. The bias
potential is given by

D𝑉 𝑟 =

2

[𝐸−𝑉 𝑟 ]
a +[𝐸−𝑉 𝑟 ]

(2.5.1)

Where V(r) is the true potential, E is the reference (boost) energy and a is the tuning
parameter that controls the depth of modified potential energy as shown in Figure 2.1.
The modified potential is
V*(r) = V(r), V(r) ³ E
V(r) + DV(r), V(r) < E
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(2.5.2)

Figure 2.1 Schematic diagram of aMD
We performed aMD simulations on RfaH-CTD to exlore the confromational transition
from a-form to b-form. We were able to explore the conversion of a-form RfaH CTD to
random coiled state.

2.6 Jarzynski Equality (JE)
I performed nine independent 60 ns SMD simulations (pulling only) on RfaH to
calculate the potential of mean force (PMF) using the Jarzynski equality (48), which
relates the non-equilibrium work done (W) with the PMF as 𝑒 IJ∆K = 𝑒 IJL where,
refers to the ensemble average. The free-energy profile can be obtained from
∆𝐹 = 𝑊 −

LO I L O

(2.6.1)

65P

where k is the Boltzmann constant. The harmonic force applied to the virtual spring
attached to the C-terminal Cα was integrated over the pulled distance to calculate the
work done over the simulation time using 𝑊 =
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P
𝑣
S

𝑓 𝑡 𝑑𝑡, where v is the pulling

speed, f(t) is the force as a function of time, and v dt=dx is a small increment in the
pulling distance. All nine simulations were used in eq. 2.6.1 to calculate the average and
the standard deviation for calculating the free-energy profile.

2.7 Adaptive Biasing Force (ABF)
To further investigate the αàβ structural transformation of the CTD in the full
RfaH, I calculated the Potential of Mean Force (PMF) using the Adaptive Biasing Force
(ABF) method implemented in NAMD. In ABF, a free-energy profile is computed using
a thermodynamic integration scheme in which the biasing force is adapted continuously
in the Hamiltonian until the system overcomes an energy barrier. ABF has proven to be a
very useful tool to investigate and explain protein interactions as well as dynamic
pathways in a complex energy landscape (79), (80).
The PMF was calculated using 20 ns ABF simulations with a time step of 0.5 fs
using rmsd as the reaction coordinate in the NAMD colvar module. The upper and lower
boundary wall constant was 310 kcal/mol and a bin width of 0.001 Å. Force samples
were accrued for 5000 steps until the adaptive biasing force was applied. The Langevin
damping constant was 1 ps-1.

2.8 Transfer Entropy (TE)
Transfer Entropy (TE) can be a valuable tool to obtain information about the
dynamics of proteins, especially in allosteric conformational changes. In addition to
quantifying important residue-residue correlated motions, TE provides a directionality of
the drive-response relationship between residues i and j through the directionality index
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Djài. TE elucidates which part of the protein drives structural transitions and which other
parts respond. For example, TE calculations illustrated the roles of helix motions on how
the information of DNA binding is transmitted in the folded protein Ets-1 (81). Recently,
TE calculations have been applied to protein folding and unfolding processes. Using long
simulation trajectories, including a 200 µs trajectory of Trp-cage that contained multiple
folding and unfolding events, Qi and Im (82) calculated a time dependent directional
index Djài which showed remarkable correspondence with the overall folding score and
further suggested that the main contribution to the information transfer entropy reflected
the folding and unfolding events. The authors performed the TE analysis for single
folding events in the trajectory and showed that the drive-response relationship is still
preserved in separate non-equilibrium events such as folding and unfolding. During such
non-equilibrium events, residues may interact differently at different times so that the
drive-response relationship is altered. However, the calculations can still identify the
residue-residue pairs that contribute most to the information transfer during the overall
folding or unfolding process.
I performed transfer entropy calculations as described in ref. (81). In this method,
the transfer entropy 𝑇#→" is calculated as conditional mutual information; 𝑇#→" =
Z

Z

Z

Z

𝐼 𝐼5VW; 𝐽5 [ |𝐼5 ] where 𝐼5 ] and 𝐽5 [ are state vectors representing positional fluctuations of
atoms i and j. The value of 𝑇#→" indicates how strongly the fluctuations of atom j are
driving the fluctuations of atom i. Directionality of the drive-response relationship can be
obtained by further calculating the normalized directional index 𝐷#→"
𝐷#→" =

P[→]

c

^ _`ab |_` ]

-

P]→[

c[

^ d`ab |d`
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(2.7.1)

If 𝐷#→" > 0, the fluctuations of atom j drive the fluctuations of atom i, and vice versa if
𝐷#→" < 0.

3. STRUCTURAL CONVERSION FROM a-HELIX TO b-BARREL IN THE
RFAH TRANSCRPTION FACTOR
3.1 RfaH Protein Structure and Function
In the RfaH CTD, the protein segment from residues 115 to 156 exists as a helixturn-helix motif when it is interacting with the RfaH NTD as shown in Figure 3.2a, but
the CTD prefers a β structure when not interacting with the NTD. Its NusG paralog
Figure 3.1b has a similar NTD structure but the CTD is never interfaced with the NTD,
and the CTD is found only in the β-barrel structure. In both NusG and RfaH, RNAP and
protein S10 binding occurs when the CTD is in its β-form, which requires breaking of the
interfacial contacts between the NTD and the CTD in RfaH. Since the α-form of the
RfaH-CTD is stabilized by interdomain interactions, it is important to examine these
interactions for understanding the structural transformation of the RfaH-CTD.
Initially, we performed 850 ns all-atom MD (also referred as conventional MD
(cMD)) and 10 ns accelerated MD (aMD) to elucidate the structural conversion of RfaHCTD from α-form to β-form. During 850 ns simulation, such structural conversion of
CTD was not observed. The shorter helix loses its helicity while the other remains intact.
Since this shorter helix was in close contact with NTD, and loss of the contact in isolated
CTD allowed greater flexibility and reduction in the secondary structure. There was loss
in secondary structure of both helices during 10 ns aMD simulations.
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I then performed REMD simulations for the CTD helix-turn-helix motif without
including the NTD. Since the motif is simulated in the absence of the NTD, it is expected
to convert to the β scaffold, as observed experimentally. Analysis of MD trajectories
showed that the implicit solvent EEF1 force field allowed a fast structural conversion
from α-helix àrandom coil àβ-conformation as well as a through sampling of
conformational space with an acceptance ratio between 41-48%. I note that given the
relatively fast structure conversion and high acceptance ratio, additional lower
temperature replicas would improve the stability of the preferred conformations. Since
both the replica exchange procedure and choice of force field affect the kinetics
information, the timescales of the observed structural conversion are not exact. However,
relative information on kinetics such as identifying rate limiting steps can be obtained.

Figure 3.1 a) RfaH structure showing both the NTD (gray) and the CTD (red).
Hydrophobic interactions at the interface between NTD and CTD are highlighted in
yellow. b) NUSG-CTD and NUSG-NTD.
To understand the role of the interfacial interactions in the structural
rearrangements of the RfaH-CTD, I also used SMD and calculated the Potential of Mean
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Force (PMF) from the ensemble average of the SMD trajectories using the Jarzynski
equality (48). SMD simulations have been valuable in understanding many biophysical
processes such as mechanical responses to biomolecules (83), (84), (47), (85), (86)
protein dissociation and conformational changes (87), (88), (89), stability of proteinprotein or domain interfaces (90), (91), (92), and ligand binding (45), (93). Through the
TMD and SMD simulations, I found that the interdomain interactions constitute the main
barrier in the α-helix to β-barrel structural conversion. Once the interfacial interactions
are broken, the structural conversion of the CTD occurs relatively easily. I identified key
residues that are involved in the interdomain motion and structural transformation.

3.2 Structural Transitions in the RfaH Carboxy Terminal Domain (CTD)
3.2.1 Conformational Sampling of RfaH-CTD
In order to elucidate the conformational space of RfaH-CTD, I calculated and
plotted in Figure 3.2 the free-energy landscape as a function of rmsd from the initial
structure, and end-to-end distance (94) at 310 K. I used the 25-ns implicit solvent EEF1
REMD simulation to obtain the probability 𝑃 𝑟𝑚𝑠𝑑, 𝑑hh for the chain to have specific
values of rmsd and dee and used 𝐹 𝑟𝑚𝑠𝑑, 𝑑hh ; 𝑇 = −𝑅𝑇 ln 𝑃 𝑟𝑚𝑠𝑑, 𝑑hh to calculate
the free-energy. In order to plot F at 310K, I gather the 310K sequences that are
distributed throughout various replicas. Multiple free-energy minima corresponding to
various conformational states of RfaH-CTD are observed. As indicated by low freeenergy regions, both α-helix as well as β-sheet structures are sampled at T=310 K. Since
the α-helix to β-structure conversion occurs relatively quickly, the β-structures are
sampled more frequently than α-helix structures for this temperature and time-window.

26

The free-energy minima corresponding to α-helix structures are observed mostly in the
range of 5<rmsd<10 Å and 5<dee<30 Å. The α-helix structures with the two helices
positioned approximately at right angle to each other occur at very high dee (~48 Å). A
region with relatively high dee (~31 Å) and intermediate rmsd (~10 Å) consists of mixed
α-helix and β-structure conformations. Similarly, several free-energy minima are
observed for β-structures, which mostly have dee<30 Å and rmsd >10 Å. Deep freeenergy minima are observed for the b-sheet structures with antiparallel stacking of bstrands. As expected in the absence of the NTD, the β-structures of the CTD are found to
be relatively more stable than the α-helix structures. Also, in examining the MD time
trajectories, once b-structure is attained, conversion back to α-helix is not observed at this
temperature.
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Figure 3.2 Free-energy surface for RfaH-CTD at 310 K in terms of rmsd and end-to-end
distance. The energy scale is given in kcal mol-1 with red color indicating low freeenergy regions and blue indicating the high free-energy regions. Typical structures for the
free-energy minima are shown with arrows.
3.2.2 Time evolution of structural transitions in RfaH-CTD
During the 25-ns window that I used for my implicit solvent EEF1 simulations, αto-β conversion was observed in all 16 replicas, but with only one replica finishing in a
conformation close to the experimentally observed RfaH-CTD β-structure. I selected the
replica that best displayed the experimentally observed CTD structure for further analysis
to investigate the details of the structural transition from α-helix à random coil àβconformation.
For the selected replica, Figure 3.3a shows the time evolution of the root-meansquare deviation (rmsd) from the initial α-helical configuration averaged over all the Cα
atoms during the structural conversion obtained from the implicit solvent REMD
simulations. The rmsd graph shows that the major structural conversion starts around 13
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ns. Once relatively stable β structure is formed, the rmsd plateaus after 20 ns. I plot in
Figure 3.3b the time evolution of the temperature showing the walk in the 16 different
temperatures for this replica. Sampling at the lowest temperature mostly occurs early,
before the helix unfolding, and late, after the β-structure formation. During the helix to
coil and coil to β-structural transition, the sampling is at higher temperatures and this
allowed a faster structural conversion. An additional 25 ns of REMD simulation with
EEF1 revealed that this β-structure spends the most time at the lowest temperature,
making it the preferred structure.

Figure 3.3 a) Root-mean-squared deviation (rmsd) from the initial structure averaged
over all the Cα atoms of the CTD during the structural conversion from α-helix structure
to β-scaffold. b) Time series of temperature exchange showing replica’s walk throughout
the temperature space.
The stages of the structural conversion of RfaH-CTD are shown in Figure 3.4, in
which I display snapshots of representative structures at various times during the replica
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exchange simulation. The supplementary movie S1 (95) gives a more detailed view of the
dynamics of the structural conversion.

Figure 3.4 Snapshots of the evolving CTD configuration at various stages during the alla to all-β structure conversion process.
In order to examine the changes in the protein structure for the selected replica in
more detail, I plot the evolution of the secondary structure of each amino acid in the CTD
in Figure 3.5a. In the helix-turn-helix motif, Helix I consists of residues 115-130 and
Helix II consists of residues 136-153. Helix I loses most of its helicity around 8 ns, as
seen in Figure 3.5a, whereas Helix II takes almost twice as much time to lose its helical
structure. This shows that Helix I is relatively unstable under the conditions in which it
does not experience tertiary interactions with the NTD. In the native state, Helix I
interacts with a NTD helix via hydrophobic interactions. Specifically, as shown in Figure
3.1, residues A122, F126, I129, F130 in the CTD make hydrophobic interactions with
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residues L50, F51, L96, I93 in the NTD. These inter-domain contacts are sufficient to
refold the CTD into the α-helical form after denaturation (13).

Figure 3.5 a) Time evolution of the secondary structure of each amino acid in the CTD.
In addition to the color legends, noticeable π-helix (red) and 3-10 helix (blue) are also
observed. b) Time evolution of the number of hydrogen bonds. c) Distribution of the
conformations in a single replica as a function of rgyr and rmsd values. The solid line
represents the MD pathway for the structural conversion and the dashed line represents
another possible pathway.
Figure 3.5a shows that Helix II starts to unravel around 12 ns, and by 15 ns both
Helix I and Helix II have completely unfolded. During the large structural change
between 12-15ns, this replica is sampling conformations at high temperatures as shown in
Figure 3.3b. The protein spends relatively less time in the intermediate unfolded state as
compared to the α-helical structure. Large-scale β-structural arrangements appear
between 15-20 ns, followed by the organization of the β-strands into a stable
configuration by 20 ns. After 20 ns, smaller fluctuations occur which are reflected in the
small fluctuations after 20 ns in the number of hydrogen bonds displayed in Figure 3.5b.
The loop region in the helix bundle (residues 131-135) remains flexible until the βstructure starts to form. Residue Gly135 is in the loop conformation in both the helix
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bundle as well as in the final β-scaffold. During helix unfolding, a noticeable fraction of
π- as well as 3-10 helical structures also transiently appear.
I also analyzed changes in the hydrogen bond pattern due to the structural
transformation by calculating the total number of hydrogen bonds between protein
backbone atoms, which is plotted in Figure 3.5b. I used an H-bond distance cut-off of 3.5
Å and angle cut-off of 30o. The time evolution of the number of hydrogen bonds is
similar to the evolution of the changes in secondary structure and also correlates with the
temperatures at which the conformations are sampled. The number of hydrogen bonds
decreases as the helices unfold. The unfolded random coil structure around 15 ns shows
the least number of hydrogen bonds, before it increases as a result of formation of
hydrogen bonds between β-strands. In the unfolded state around 15 ns, a slight increase in
hydrogen bonding occurs because of a collapsed random structure. These non-native
contacts break within a few nanoseconds and allow the β-strands to align and nucleate
into the first β-hairpin. As discussed later, from this time onwards, the hydrogen bonding
pattern trends upwards but with oscillations during structural rearrangement of β-strands
until the final β-scaffold is reached.
Figure 3.5c displays the distribution of the structures having specific radius of
gyration (rgyr) and rmsd values. In the MD simulations, the pathway for structural
conversion from all α-helix to an all β-conformation that is most similar to the
experimentally observed structure proceeds via a completely unfolded intermediate
structure, as shown by the solid line in Figure 3.5c. However, other possible pathways
may exist (dashed line in Figure 3.5c) in which structural conversion to β-conformation
can occur concurrently with unraveling of α-helix structure. Such a process in a different
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protein has been shown to be orders of magnitude faster than the structure conversion that
involves a completely unfolded intermediate (96). Similarly, a recent investigation of the
α-helix to β-structure transition in the human islet amyloid peptide fragment with REMD
simulations at atomistic detail also showed two distinct mechanisms, one without
unraveling the helix into random coil and the other with a random coil intermediate (97).
On the basis of the observed pathway alone, the sampled structures that have intermediate
rmsd but low rgyr in Figure 3.5c are off-pathway structures. However, they may belong
to the on-pathway structures for the alternate pathway represented by the dotted line. A
plot of the free energy profiles of the observed pathway and a possible alternate pathway
based on the free-energy landscape of Figure 2 is given in the supplementary figure,
Figure S1 (95). In our simulations with the EEF1 implicit solvent model, I did not
observe the structural conversion via the faster concurrent β formation pathway, which
can potentially be revealed by more detailed and long time-scale all-atom simulations.

3.2.3 Folding into a β-barrel scaffold
Starting from the unfolded state configuration around 15 ns, folding into βstructure starts by nucleating a β3-loop-β4 hairpin structure as shown at 16 ns in Figure
3.4. Here, β3 consists of residues 137-144, whereas β4 consists of residues 147-154.
Residues 145 and 146 form the loop segment that connects the β3 and β4 strands. Once
this hairpin structure is formed, another β-strand, β2 formed by residues 127-134, aligns
with β3 very quickly (~1 ns) as seen in Figure 3.4 at 17 ns. The number of hydrogen
bonds increases steadily during the formation of β-sheet structure involving β2, β3, and
β4 that occurs around 17 ns. The number of hydrogen bonds continues to increase due to
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partial formation and alignment of β1 formed by residues 116-119. However, the initial
hydrogen bonding to β1 is transient as seen in Figure 3.5b. After peaking at 17 ns, these
hydrogen bonds break and rearrange. Therefore, formation and proper alignment of β1
takes longer (~3 ns). The longer time for proper alignment of β1 is partially due to the
higher entropy of the loop segment connecting β1 to β2 which consists of eight residues,
as compared to only two residues in the loop segment connecting β2 to β3.
Oscillations with a period of a few nanoseconds in the hydrogen bond pattern
provide additional insight into the mechanism for this protein to fold into a β-motif. The
antiparallel β-sheet structure formed with β1 through β4 is slightly curved and makes it
possible for β5 to wrap around the β-sheet structure and align with β1 in an antiparallel
fashion. This wrapping gives an additional twist to the β-scaffold, resulting in a barrellike shape. With the implicit solvent EEF1 model, the final β-structure is still relatively
flat as compared to the experimentally determined β-barrel structure, and the structure did
not show improvement upon further REMD simulation with EEF1. Therefore, I selected
a structure that is closest to the native β-barrel structure for further relaxation with an allatom, explicit solvent MD simulation.

3.2.4 β-structure refinement with all-atom simulation
When relaxed using the all-atom CHARMM 27 force field with explicit solvent,
the β-structure tends to be organized closer to the native state of the experimentally
determined all-β configuration with an rmsd of ~5 Å and Q-score of ~0.4. Figure 3.6
displays the structural overlap between the experimentally determined NMR structure
(red) of the β-barrel and the MD simulated structure (blue). The order and orientations of
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the β-strands, as well as the overall barrel shape from the simulation match relatively well
with the NMR structure. An additional 50 ns simulation at 300 K shows very small
change in the rmsd, suggesting that the obtained structure is quite stable. I also compare
the specific amino acid residues making up the β-strands. The β-strand residues match
reasonably well, but with some differences that prevent the MD β-strands from aligning
perfectly with the experimental structure. The β2 strand from the simulation (amino acids
127-134) extends longer than the experimental structure (127-130) and the MD β3 strand
starts one residue earlier at 137, leaving only two amino acids for the MD connecting
loop as compared to seven amino acid residues in the experimentally observed structure.

Figure 3.6 Left: Comparison between the β-barrel structure from the MD simulation
(blue) and the NMR configuration (red; NMR structure 2LCL from ref. [10]). Right:
Comparison of amino acid residues that form various β-strands in the β-scaffold.
3.3 TE Calculations on the a-helix unfolding and b-barrel formation
I performed information transfer entropy (TE) analysis for our selected REMD
trajectory using Cα backbone information. Since the trajectory consists of two major
events, unfolding of α-helix to random coil and folding to a b-structure as shown in
Figures 3.3 and 3.5, I calculated Djài of eq. (2.7.1) for the unfolding event and the folding
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event separately. By calculating TE separately for helix unfolding and formation of beta
structures, the role of each residue in each of these processes can be examined. The
trajectory for the TE analysis for helix unfolding was chosen to be the 0-14 ns window.
Since the protein configuration was saved every 2 ps, there were 7,000 frames in the
trajectory for this process. I display the Djài values for all i,j residue pairs for the helix
unfolding process in Figure 3.7a. The values were color coded as shown in the color bar,
with positive values in red, brown or yellow and negative values in blue. Red means that
the residue on the y-axis drives the residue from the x-axis. For the helix unfolding,
residues on Helix II appear to be a strong driver for several residues in both Helices I and
II. Specifically, Helix I residues Ile117, Ile118, and Helix II residues Pro133, Asp134
appear to respond strongly to the residues between Leu142 to Glu158 which are mostly in
Helix II. In general Helix I experiences much larger structural fluctuations as compared
to Helix II. Consistent with the transfer entropy analysis in ref. (82) in which driving
residues were found to be in segments with more robust secondary structure, I found that
residues in Helix II which has a more stable secondary structure drive the residues in
more floppy regions in the chain. Experiments show that in the absence of appropriate
CTD/NTD contacts, the preferred conformation of the CTD is the β-barrel structure (13).
Our results show that in the absence of NTD tertiary contacts, Helix-I is not stable and
therefore unravels relatively quickly. This is reflected by the transfer entropy calculations
which show that Helix-I is primarily a responder. These observations suggest that the
helix-I is most likely formed by nucleation at the CTD/NTD interface, instead of first
forming the helix and then making the tertiary contacts with NTD.
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Figure 3.7 Normalized transfer entropy directional index Djài for two different stages in
the αàβ conversion process: a) α-helix unfolding and b) β-scaffold formation. Red means
that the amino acid on the y-axis drives the response of the amino acid on the x-axis. c)
major driver (red) and responder (blue) amino acids in helix unfolding and d) in β-barrel
folding.
The second part of the trajectory was taken from 14 ns to 25 ns of the REMD
trajectory and included a total of 5,500 frames. As displayed in Figure 3.7b, the driving
amino acid residues are different for β-structure formation from those in helix unfolding.
However, the responding residues fall in the same general segment of the protein. Major
drivers M140, N144, K148, and M140 are in β3 and β4, which form the β-hairpin
structure early on during the β-structure folding. Residues between Met140 and Leu145
in β3 are strong drivers for residues Gly121, Phe123, Glu136, Ser139, Val154, Glu158,
and Arg160. Similarly, residues Asp147, Lys148, Glu149, and Lys151 are weak drivers.
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Residues Ile146 and Ile150 are strong responders to many other residues. Isoleucine 146
is in the flexible loop region between β3 and β4 and Ile150 is in β4. In both cases, the Ile
responders are exposed to the solvent, which is consistent with the observation that
driving residues are mostly buried in the hydrophobic core (82). During the β-folding,
information transfer occurs among amino acid residues that are not necessarily in close
proximity. In addition, many amino acids have different transfer entropy identities,
drivers for some residues, responders for others. In Figure 3.7c and 3.7d, I color code
only the major drivers and the associated responders from Figure 3.7a and 3.7b,
respectively.

3.4 Full RfaH Structural Fluctuations and Correlated Motions
In the RfaH-CTD, the protein segment from residues 115 to 156 exists as a helixturn-helix motif when it is interfaced with the RfaH-NTD, but the CTD prefers a β-barrel
structure when not interfaced with the NTD. Its NusG paralog has a similar NTD
structure but the CTD is never interfaced with the NTD, and the CTD is found only in the
β-barrel structure. In both NusG and RfaH, RNAP and protein S10 binding occurs when
the CTD is in its β-form, which requires breaking of the interfacial contacts between the
NTD and the CTD (Table S1) in RfaH. Since the α-form of the RfaH-CTD is stabilized
by interdomain interactions, it is important to examine these interactions for
understanding the structural transformation of the RfaH-CTD.
I performed a 100 ns NVT simulation on the native state structure of the full RfaH
with the CTD in the α-helix form. Figure 3.8a shows overlays of 100 sampled
conformations taken from the 100 ns trajectory. These, together with the root mean
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squared fluctuations (rmsf) for all Cα plotted in supplemental Figure S1 (34) provide
insight on the conformational fluctuations during the simulation. The rmsf figure (Figure
S1 a) shows that both the NTD and the CTD are stable but large fluctuations occur in the
linker and loop segments, as expected. Specifically, the segment composed of residues
35-45, corresponding to the loop region of the β-hairpin motif in the NTD shows
particularly large fluctuations. Also, the long NTD-CTD linker segment (residues 101114) shows large flexibility.

Interestingly, the NTD helix (90-100) at the domain

interface is slightly more flexible than the CTD helices (Helix I and Helix II).
Dynamic network analysis can be used to understand the correlated molecular
motions (98), (99), (100). Dynamic analysis from the 100 ns NVT simulation of the full
RfaH resulted in 11 communities that are highlighted in color in Figure 3.8a and the
constituent amino acids for each community are listed in Table S2 (34). A community is
composed of amino acids that are in close proximity and have highly correlated motions.
The size of the circle for each node is proportional to the number of residues in each
community, and the line thickness represents the inter-community edge weights. As
shown in Figure 3.8b, community H (lime green) in the NTD β-sheet core region seems
to have the most correlated motion with other communities. I found three communities
(C, D, G) that each are composed of residues from both the NTD and CTD. The amino
acids that comprise these three communities are highlighted in Figure 3.8c.

By

examining the composition of each community, I was able to locate the amino acids pairs
that most strongly bridge the NTD to the CTD within each community. These pairs are
shown in Figure 3.8c: L96-F126 (community C), F33-F130 (community D), and F81I118 (community E). In all of these cases, phenylalanine residues seem to play important

39

roles in modulating the interdomain motions. F126 plays a major role in interdomain
communication and therefore it is a functionally important residue for modulating the
domain separation. Alanine substitution using FoldX (101) revealed that mutating F126
with alanine resulted in an increase in DDG by ~3 kcal/mol (Figure S1 (b) (34), indicating
that the F126A substitution destabilizes the domain interface, and is one of the largest
DDG among all residue positions upon alanine mutation. Figure S1 (34) (b) also shows
that more than 75% of the interface residues do not favor alanine substitution. I
performed a 100 ns MD simulation on the RfaH-F126A mutant and investigated its
kinetic/dynamic behavior. Figure S2 shows that the Ca rmsf for the WT and the RfaHF126A are comparable. The F126A mutation caused slightly larger fluctuations in the
loop/turn region (residues 35-50) in the β-turn-β motif of the NTD, but the linker segment
connecting the two domains, as well as the some other loop segments are more restricted
in the mutant. The restriction of loop segments in the mutant are due to the interactions
with the CTD tail segment (residues 158-162), which became flexible in the WT after
~50 ns, whereas it remained intact for the entire 100 ns in F126A. The network analysis
displayed in Figure S2 (34) shows that the F126A mutation causes changes in the
community structure. Specifically, the interdomain correlated motion through F126
disappears in the mutant.
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Figure 3.8 RfaH structural fluctuations and correlated motions. a) Structural fluctuations
of amino acids in the full RfaH determined from MD simulations. b) Community map of
RfaH showing 11 different communities. The size of the circle for each node is
proportional to the number of residues in each community, and the line thickness
represents the inter-community edge weights. The communities are colored as in Figure
3.8a. c) Three communities especially relevant for the interdomain interactions are
highlighted.

3.5 Structural transformation with TMD:
The α-helical conformation of the CTD (α-CTD) in the full RfaH was targeted to
map onto the β-barrel CTD (β-CTD) and vice versa using targeted MD. Several targeted
MD simulations of length 10 ns were performed. Each simulation resulted in conversion
to the desired target structure. A typical α-helix to β-barrel structural transformation
process is shown in Figure 3.9, which shows snapshots of the protein conformation at
various stages of the structural transformation. In general, the α-helix secondary structure
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is lost by the mid-part of the simulation where the target RMSD has decreased by 50%.
For the CTD, once the tertiary contacts with the NTD are lost as well as the CTD helicity,
folding into the CTD β-structure begins to occur. By the end of the simulation, CTD βsheets are fully formed and arranged into the final β-barrel structure. The final structure
was within 0.94 Å rmsd of the experimental structure (11). To confirm the stability of the
transformed structure, I performed a 100 ns conventional MD and found that the βstructure was very stable at 300K.

Figure 3.9 Snapshots of RfaH conformations during TMD simulation for the α-CTD to βCTD conversion in the full RfaH. The N-terminal domain is shown as gray and the
transforming C-terminal domain is highlighted in green.
I plot the time evolution of the secondary structure of the full RfaH in Figure
3.10a from the TMD. The structural transformation of the CTD (residues 115-162) can be
divided into two parts: helix-to-coil transition (approximately 2–5 ns), and coil-to-beta
transition (approximately 6-9 ns). The total number of intradomain CTD hydrogen bonds
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also follows this pattern, as shown in Figure 3.10b. Hydrogen bonds are calculated with a
distance cut-off of 3.5 Å and an angle cut-off of 30°. As discussed later, the coil structure
that is intermediate between the α-helix and β-barrel structure is in fact a collapsed
globule state of the protein.

Figure 3.10 Results from RfaH TMD simulations for the α-CTDà β-CTD structural
conversion. The CTD is composed of residues 115-162. a) Time evolution of the
secondary structure b) Time evolution of the number of intradomain hydrogen bonds in
the CTD. The number of hydrogen bonds decreases as the CTD helices unfold (2-5 ns)
but increases with the formation of the CTD β-structure (6-9 ns).
3.5.1 Unfolding of the helix to the collapsed coil state
As shown in Figure 3.10a, the CTD begins to lose its Helix II helicity around 2
ns. Interestingly, Helix I (residues 116-131) retains its structural integrity better than
Helix II (residues 135-156). This result using the full RfaH is in contrast to previous
computational results (95), (102) obtained for the isolated CTD. Simulations for the
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isolated CTD showed faster unfolding of Helix I because of the absence of the
interdomain tertiary interactions. On the basis of amino acid secondary structural
propensity calculations, Balasco et al. (102) showed that Helix I has weaker stability as
compared to Helix II, whereas the interdomain tertiary interactions with the NTD for both
helices are comparable. Targeted MD results from the simulations of the full RfaH show
that in the presence of the NTD interactions, the structural transformation proceeds
through the pathway that rearranges the amino acids in Helix II first. I further explored
this process with steered MD simulations, as discussed later.
As seen in Figure 3.10b, during the helix unfolding the number of hydrogen
bonds decreases by ~70%. Although some residual hydrogen bonds are still present in the
coil state (5-6 ns), the CTD helix secondary structure is completely lost by 5 ns (Figure
3.10a). Initially, Helix II is stabilized by both CTD Helix I-Helix II interactions as well as
the NTD-CTD inter-domain interactions during the structural conversion. Part of Helix II
unravels to form a loop/turn at 2 ns, and then a transient 310-helix at 3 ns. The CTD interhelical contact is lost once Helix II is sufficiently destabilized. Key stages during the
helix to coil conversion of the CTD are shown in Figure 3.11.
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Figure 3.11 Conformations of the CTD at various stages of structural transformation
during helix unfolding (top, left to right) and beta-folding (bottom, right to left).
A closer examination of the CTD coil structure (5-6 ns) reveals that it has significant
internal hydrophobic interactions, making it more like a molten-globule state than a
random coil structure. This is also evidenced by only a small change in the solvent
accessible surface area (SASA) calculated for the hydrophobic amino acids in the CTD
(Figure 3.12, top). This hydrophobic collapsed state constitutes the intermediate structure
that connects the CTD α-helix and β-barrel basins in the energy landscape. This result is
in contrast to the observed mechanism for the structural transformation in the isolated
CTD (95) in which the helices first unfolded to a random coil structure, followed by the
folding into the β-barrel.
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Figure 3.12 Solvent accessible surface area (SASA) calculated for the hydrophobic amino
acids in the CTD (top-green) and at the CTD-NTD interface (bottom-red).
3.5.2 Folding into the β-barrel
The structural rearrangement of the collapsed globule state of the CTD around 6
ns in Figure 3.10a allows the formation of the first anti-parallel β-strands. At this point,
the SASA for the CTD hydrophobic residues (Figure 3.12, top) increases slightly and
then steadily decreases as the hydrophobic residues bury due to reorganization. The
formation of the first anti-parallel β-strands also causes the SASA for the NTD-CTD
interface residues (Figure 3.12, bottom) to increase due to increased exposure of the
hydrophobic residues. During 7-8 ns, the middle two β-strands of the CTD, β2 (residues
127-133) and β3 (residues 138-143) form first. This is followed by the alignment of β1
(residues 115-117) with β2 as well as the alignment of β4 (residues 150-155) with β3.
Finally, β5 (residues 160-161) forms and aligns with β1 to complete the β-barrel
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structure. The above mentioned sequence of β-structure formation is consistent with
observations by Li et al. (103) and Xiong et al. (10) through MD simulations.
To investigate the dynamics of the resulting RfaH β-CTD, I performed a 100-ns
conventional MD simulation and found the β-structure of the CTD is stable at 300K.
However, the absence of the interdomain contacts, combined with the flexible nature of
the linker, allows large-scale diffusive motions of the β-CTD, which can be important for
its function. In Figure S3, I plot the time evolution of the CTD-NTD center of mass
separation distance (dcm), as well as the root-mean-squared distance (rmsd) from the
starting structure during the 100 ns simulation and compared these with the results for the
RfaH α-CTD. The rmsd and dcm for the RfaH β-CTD shows significant fluctuations as
compared to those of the RfaH α-CTD. As the linker segment undergoes large
fluctuations, dcm tends to increase in the β-CTD whereas the dcm for the closed form αCTD remains constant due to CTD-NTD interactions. In addition, the rmsf for the NTD
show that the residue fluctuations are comparable in the beta and alpha forms, suggesting
that the NTD integrity is not significantly perturbed by domain dissociation. However,
the intradomain network connectivity in the NTD changes significantly upon domain
separation (Figure S2) (34) I also observed that when the E48-R138 interdomain saltbridge interaction breaks, E48 makes a different ionic interaction with R11 which is
within the NTD, giving additional structural stability. This R11-E48 interaction was also
observed in the 100-ns simulation of the RfaH in the α-CTD form when the E48-R138
interaction is intermittently broken.
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3.5.3 Dynamics of the interdomain contacts
The RfaH-CTD in the α-helical state is stabilized by interdomain contacts. I
calculated the time-evolution of the fraction of native contacts (Q) of the NTD-CTD
interfacial residues and CTD intradomain contacts and plotted the results in Figure 3.13a.
Native contacts were defined as contacts between any heavy-atoms within 4 Å of
distance in the native state configuration. The NTD-CTD interfacial native contacts are
almost completely lost by 4 ns. Intradomain alpha CTD contacts are lost by 6 ns, at which
time the native contacts for the CTD β-structure begin to form. Interestingly, some
residue pairs that were part of the native intradomian contacts in the α-CTD were also
part of the native intradomian contacts in β-CTD. Specifically, residue pairs G135-K139
and A128-L141 were within a cutoff distance of ~4 Å in both the α-helix and β-structure
of the CTD. Persistence of the hydrophobic contact between residues A128 and L141 is
an interesting feature of the structure conversion.
One of the major interdomain interactions in the RfaH with α-CTD is the saltbridge interaction between E48 and R138. As shown in Figure S1 (34), alanine
substitution at either E48 or R138 destabilizes this interdomain interaction. Similarly,
E48S mutation increased the DDG by 0.82 kcal/mol. The alanine substitution is consistent
with the experimental observation (11) that E48S mutation favored the dissociated state
leading to the β-barrel structure of the CTD. Figure 3.13b shows the distance (Dr)
between the anionic carboxylate oxygen of the E48 side chain and the cationic
ammonium nitrogen of the R138 side chain. The distance Dr remains around 5Å until 3
ns but increases steadily once the salt-bridge is broken. The time evolution of the
interdomain contacts in Figure 3.13a shows a sharp decrease in Q around 4 ns, which is
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when the salt-bridge interaction is completely broken. Therefore, the E48-R138 saltbridge is one of the last interdomain contacts that are still present during the structural
transformation. This is explored further with SMD in the next section.

Figure 3.13 a) Fraction of the native contacts Q at the NTD-CTD the interface (red), and
intradomain for the CTD for α-CTD (green) and β-CTD (blue). b) Distance (Dr) between
the E48 oxygen and the R138 nitrogen that are involved in the interdomain salt- bridge
interaction.
3.6 Potential of Mean Force Using ABF
To further investigate the αàβ structural transformation of the CTD in the full
RfaH, I calculated the Potential of Mean Force (PMF) using the Adaptive Biasing Force
(ABF) method implemented in NAMD, and display the results in Figure 3.14. In ABF
method, a free-energy profile is computed using a thermodynamic integration scheme in
which the biasing force is adapted continuously in the Hamiltonian until the system
overcomes an energy barrier. The calculation of PMF using ABF method has proven to
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be a very useful tool to investigate and explain protein interactions as well as dynamic
pathways in a complex energy landscape (79), (80).

Figure 3.14 PMF as a function of rmsd for the structural transformation of the RfaHCTD.
Figure 3.14 shows the calculated PMF with the root-mean-squared-deviation
(rmsd) as the reaction co-ordinate. The rmsd is calculated using a starting reference
structure that is obtained after a 100 ns equilibration simulation of the full RfaH with the
alpha form of the CTD. Figure 3.14 shows that readjustment (AàC) of the residues at the
CTD-NTD interface requires overcoming a large barrier B and ultimately leads the
system to an especially low free-energy configuration at C. The deep basin at C
corresponds to a structure that has subtle, but important changes in amino acid positions
and interactions compared to the initial structure in A, which represents the native state
basin. Specifically, a slight bending in the CTD Helix I allows its amino acid I118 to
make a hydrophobic contact with the CTD tail residue V154 as shown in Figure 3.15a.
Similarly, the NTD residue A91 makes a hydrophobic contact with the CTD tail residue
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F159. This interaction also allows the CTD tail segment (residues 158-161) to align with
the NTD-CTD linker segment (residues 110-113) in an antiparallel fashion. Both the
linker segment and the CTD tail segment were parts of the segments that were added
using Modeller and their interactions in this region seem to yield a more compact and
stable structure.

Figure 3.15 a) Snapshot of the structures corresponding to state A (left) and state C
(right) showing the rearrangement of the hydrophobic residues in the CTD. b)
Displacement of I93 of the NTD helix in state A (left) slightly exposes the hydrophobic
core (right, state C).
The changes in structure from A to C in Figure 3.14, due to small rearrangements
of the CTD may be functionally important. For RNAP binding to RfaH, the clamp helix
known as β’ CH of the RNAP β-subunit binds to the RfaH NTD hydrophobic region
composed of residues W4, Y54 and F56 (17) (Figure 3.15b). This binding of β’ CH is
important for reducing the transcriptional pausing and excluding the RNAP binding of
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NusG-NTD (11). In the native state (A of Figure 3.14 and the left side of Figure 3.15b),
these hydrophobic residues interact with I93 of the NTD helix and form a completely
buried hydrophobic core, which may not allow the β-subunit binding. However, in
structure C (right side of Figure 3.15b), this NTD hydrophobic core is slightly exposed as
the Y54-I93 interdomain hydrophobic contact is broken as I93 is pulled away by the CTD
Helix II through a hydrophobic interaction with F126.
Figure 3.14 shows a large barrier separating states A and C and overcoming the
large barrier at B is not possible merely because of thermal fluctuations, but requires
assistance. It was suggested (17) that the ops element binding at another binding site
(residues R16 and R73) in RfaH triggers the domain separation and subsequent binding
of the RNAP. Consistent with the suggested mechanism, the minimum at C might
constitute the structure that is accessible for RNAP binding. These structural changes
present correlations with the functionally relevant structures, though I note that the
allosteric changes caused by the ops binding may be different from the structural changes
observed here under biasing forces.
The transition from C to D in Figure 3.14 involves another large barrier in the
free-energy profile. The structure corresponding to the state D exhibits significant solvent
exposure of the hydrophobic core residues at the RNAP binding site suggests that the
RNAP β-subunit binding may facilitate the CàD transition and allow further domain
separation. The complete domain separation occurs when the rmsd exceeds 6 Å, with a
corresponding domain-domain distance of ~16 Å. Once the domains are separated,
significant structural changes (Figure 3.14, Structures E, F, G) take place during the helix
unfolding and beta-structure formation. The free-energy plot shows a rugged landscape,
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as expected for the calculations with rmsd as a reaction coordinate (80). The β-structure
formation occurs between rmsd 9 to 11 Å. The state E in Figure 3.14 corresponds to a
structure that shows complete loss of the CTD helicity as well as the initiation of the
antiparallel β-sheet. After overcoming a small free-energy barrier, β-structure formation
is completed at state G. Most structures beyond state G are part of the native state basin
of the β-CTD.

3.7 Interdomain and CTD Interhelical Interactions Using SMD
To further investigate the NTD-CTD interdomain, as well as the CTD
intradomain interactions, I performed Steered Molecular Dynamics (SMD) simulations
on the full RfaH. Before applying the pulling force, the system was first equilibrated for 5
ns in an NPT simulation in a long rectangular box with enough size to accommodate the
pulling. The N-terminal Cα atom was held fixed and a dummy atom pulls the C-terminal
atom Cα as the SMD atom for 10 ns, followed by another 10 ns without pulling to allow
the molecular system to relax from mechanical stretching. The process was repeated until
the SMD atom was close to the box edge, with a final end-to-end distance (94) of ~130
Å. Thus, SMD simulations were performed for intervals (0-10, 20-30, 40-50, 60-70,
80-90, 100-110, 120-130) ns with relaxation simulations in-between. The
pulling/relaxation simulation is displayed in Movie S1 (34).
Figure 3.16 shows representative snapshots of various intermediate stages during
the mechanical stretching. After the initial rearrangement of the CTD loop segment, the
positions of the CTD helices as well as the NTD helix at the interface are affected around
40 ns. Consistent with our description given above with respect to Figs. 3.14 and 3.15
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and the ABF simulations, Figure 3.16 shows (40 ns) that the NTD helix initially moves
together with the CTD helices, opening up the NTD hydrophobic pocket at the RNAP
binding site (residues W4, Y54 and F56). After 45 ns of pulling (80 ns frame in Figure
3.16), contacts between the CTD helices and the NTD helix weaken, which ultimately
lead to the separation of the CTD from the NTD helix. As shown in Figure S5 (34), the
SASA for the hydrophobic core opens up around 100 ns due to a slight movement of I93.

Figure 3.16 Snapshots of protein conformations at 1 ns, 40 ns, 80 ns, and 120 ns from the
SMD pulling and relaxation trajectory.
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Figure 3.17 Various dynamic and structural parameters as a function of time during
SMD: a) force profiles during pulling intervals, b) number of hydrogen bonds during
SMD (red) and relaxation (blue) c) secondary structural conversion, and d) Distance (Dr)
between the E48 oxygen and the R138 nitrogen.
The SMD simulation is set up so that the dummy atom (attached to the CTD Cα
SMD atom) travels at constant velocity while being pulled requires a pulling force that
varies in strength in response to the protein’s resistance. The helical form of the CTD is
stabilized by interdomain interactions with the NTD, which include the E48-R138 saltbridge (involving the CTD Helix II) and other hydrophobic and hydrogen bond
(involving both CTD helices). The force profile displayed in Figure 3.17a shows a
general increase in the pulling force with time until a large drop at 80 ns. The force rises
again, and another significant drop in force is observed around 90 ns that coincides with
breaking of major interdomain interactions, including the E48-R138 salt-bridge and some
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hydrogen bonds. Hydrogen bond analysis (Figure 3.17b) shows an initial increase in
hydrogen bonds due to rearrangement of the CTD-tail segment (residues 158-162).
Figure 3.17c displays the changes in secondary structure of all residues during the pulling
and relaxation. At around 60 ns, a significant reduction in helicity is observed for the
CTD Helix II, whereas Helix I is relatively unperturbed and retains most of its secondary
structure. This is consistent with our results presented above in Figure 3.10. As shown in
Figure S6 (34), the interdomain interacting hydrophobic residues F33-F130 separate in
two stages. They begin to separate and become more exposed to the solvent (increasing
solvent accessible surface area - SASA) around 80ns, which allows solvent molecules to
penetrate the interfacial region, weakening the interdomain interactions (104) facilitates
breaking of the E48-R138 salt-bridge interaction around 90 ns (increasing Δr in Figure
3.17d) and increases the SASA of E48-R138 (Figure S6) (34). As the E48-R138 saltbridge breaks, the CTD moves far away from the NTD and the F33-F130 separate
further, resulting in a larger SASA.

3.8 Calculation of Potential Mean Force Using JE
I performed nine independent 60 ns SMD simulations (pulling only) to calculate
the potential of mean force (PMF) using the Jarzynski equality, which relates the nonequilibrium work done (W) with the PMF as 𝑒 IJ∆K = 𝑒 IJL where,

refers to the

ensemble average. The free-energy profile can be obtained from
∆𝐹 = 𝑊 −

LO I L O

(3.8.1)
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where k is the Boltzmann constant. The harmonic force applied to the virtual spring
attached to the C-terminal Cα was integrated over the pulled distance to calculate the
work done over the simulation time using 𝑊 =

P
𝑣
S

𝑓 𝑡 𝑑𝑡, where v is the pulling

speed, f(t) is the force as a function of time, and v dt=dx is a small increment in the
pulling distance. All nine simulations were used in eq. 3.8.1 to calculate the average and
the standard deviation for calculating the free-energy profile. Figure 3.18 shows the
resulting free-energy profile as a function of M1-CαàL162-Cα end-to-end distance, dee.
State B at 40 Å (~15 ns) represents the native state minimum after the rearrangement of
the 158-162 CTD tail segment residues from structure A, and before any structural
changes occurred at the NTD-CTD interface. From B to C, the initial transient
interactions of the tail segment with the NTD are broken, followed by the rugged energy
landscape from state C to D representing multiple structural transitions. The minimum at
D around 110 Å (~ 56 ns) corresponds to the structure in which the CTD is mostly
detached but the E48-R138 salt-bridge is still intact. The final, major barrier between D
and E corresponds to breaking of the salt-bridge interaction. This is followed by the
complete detachment of the CTD at E, where all interdomain contacts are lost. At this
stage, the CTD-helices still retain their secondary structure as a helix-bundle. The PMF in
Figure 3.18 calculated from SMD describes the results of the pulling simulations that are
relevant for AFM experiments.
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Figure 3.18 PMF as a function of end-to-end (Cα-Cα) distance between M1 and L162.
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4. INTERDOMAIN SALT-BRIDGES IN THE EBOLA VIRUS PROTEIN VP40
AND THEIR IMPORTANT ROLES
4.1 Dynamical Analysis of the Closed-form Structure
MD simulations on the wild-type (WT) VP40 as well as on several mutants were
performed to investigate the interdomain interactions that are important in stabilizing the
closed-form structure, the sequence of steps that allow the CTD to disengage from the
NTD, and the interactions that facilitate domain-domain association into the closed form.
The effects of the removal of some important salt-bridges that were identified
computationally were further investigated experimentally by live cell imaging.
In many proteins, the CTD-tail segment interactions affect the protein
conformational dynamics and play important functional roles (105-108). Though not
resolved in the x-ray crystal structure, the VP40 CTD-tail segment (residues 320-326)
has been shown to be important for regulating oligomerization. This is evidenced by the
fact that the removal of the CTD-tail segment leads to spontaneous oligomerization of
VP40 and membrane binding in vitro (109). This is further supported by the observation
that the VP40 in its closed-form is stabilized by latch-like interactions between an
unstructured region of the N-terminal domain and the C-terminal tail region(110). In
order to investigate the NTD-CTD interactions involving the CTD-tail segment, I
modeled this segment by inserting the missing residues 320-326. The modeled CTD-tail
segment in the closed-form structure was a random coil structure with no contacts with
the NTD. Starting from this conformation, I performed eight independent MD
simulations for 50 ns each (total of 400 ns) and monitored the CTD-tail interactions with
the NTD. I observed the latch-like interactions with the NTD via a hydrophobic patch as
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well as the D45-K326 salt-bridge interaction in four of the eight simulations. Figure S1
(111) displays the representative trajectories that show the formation of the latch. The
interdomain contacts involved in the latch are highlighted in Figure S2 (111). Once
formed, the latch is stable for several nanoseconds (~3 to 30 ns) before breaking. The
flexibility of the CTD tail segment resulting from the transient stability allows the
separation of the CTD from the NTD, as required for higher order oligomerization of the
VP40 dimers. In addition, membrane association may make it easier for the latch to
release(110) to facilitate the VP40 hexamerization in the membrane.
In order to explore the interdomain as well as intra-domain interactions and
residue-residue contacts, I used 10 ns of the trajectory from the region with the intact
latch and calculated a contact map for the VP40 structure using Carma (112). Figure 4.1a
shows the resulting contact map obtained with a distance cut-off of 5 Å. Residues 44-201
belong to the NTD and residues 202-326 belong to the CTD. The lower right block
displays the interdomain contacts. This contact map allows us to identify all interdomain
interactions and in this paper, I focus on interdomain salt-bridges and hydrophobic
interactions. Salt-bridge interactions were identified with a cut-off distance of 4 Å and are
shown in Figure 4.1b. A total of five interdomain salt-bridge interactions were obtained:
D45-K326, D56-K256, E76-K291, R148-D312, and E160-K212. As discussed later, the
D45-K326 salt-bridge is important in guiding domain association for the open- to closedform structure.
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Figure 4.1 (a) Amino acid contact map of the VP40 protomer. The blue regions (<5Å) in
the lower right block display the NTD-CTD interdomain contacts within 5Å distance (b)
VP40 inter-domain salt-bridges. Red are negatively charged amino acids and blue are
positively charged.
4.2 Forced pulling and Dissociation of Domains
I used Steered Molecular Dynamics (SMD) to investigate the relative strengths of
interdomain interactions by pulling the center of mass of the C-terminal domain (CTD)
away from the harmonically restrained N-terminal domain. For SMD simulations, the last
frame of the 5-ns equilibrium NVT simulation was taken as the initial structure and
solvated again in a larger rectangular box to allow room for extension. In order to focus
on the relative motion of the NTD and the CTD, translation and rotation was prevented
by harmonically restraining the protein during heating and equilibration. After that, the
NTD was kept harmonically restrained and the center of mass of the CTD was pulled
away from the NTD using SMD. The protein was aligned so that the NTD-CTD interface
is approximately perpendicular to the pulling direction (-x). Stages in the resulting
domain separation due to the SMD pulling are shown in Figure 4.2.
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Figure 4.2 Domain separation during the SMD simulation in which the CTD (circled) is
pulled away from the NTD. Residues D45 and K326 that participate in the interdomain
salt-bridge are highlighted. This salt-bridge that participates in the latch remains intact for
20 ns and restricts CTD-NTD relative reorientation even when the domains are well
separated.
I performed seven 25-ns SMD simulations and averaged the force profiles for
pulling the CTD center of mass away from the harmonically restrained NTD. During the
initial stage of pulling, the SMD force continuously increase because all NTD-CTD
interactions are intact and undergoing stress as shown in Figure S3 (111) . I monitored
the interdomain interactions during the pulling for a representative trajectory and the
results are displayed in Figure 4.3. Figure 4.3a shows the SMD force necessary to move
the center of mass of the CTD at a constant speed of 2 Å/ns as it disengages from the
NTD. The SMD force curve initially increases and reaches a peak of 700 pN around 4 ns
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(region A in Figure 4.3a) and then suddenly drops to approximately 300 pN. Just before
this sharp drop in the SMD force, the solvent accessible surface area (SASA) at the
interface of the NTD and CTD suddenly increases (Figure 4.3c) by 800 Å2, suggesting
the separation of the interdomain hydrophobic interface and the exposure of hydrophobic
residues to water. This may be precipitated by the breaking of hydrogen bonds (Figure
4.3b) and the breaking of the R148-D312 salt-bridge (Figure 4.3d) that occur at
approximately 1.5 ns. In addition, two other salt-bridges, D56-K256 and E76-K291, are
each stretched and weakened before 1.5 ns. Thus, it appears that the weakening of
specific salt-bridges and hydrogen bonds permits enough flexibility to allow water to
enter into the hydrophobic domain-domain interface.

Figure 4.3 a) SMD force necessary to keep the CTD moving at constant speed away from
the NTD (gray curve: full data, red curve: time averaged data with 200 ps windows) b)
Time evolution of the number of hydrogen bonds in the interface, c) solvent accessible
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surface area (SASA) of hydrophobic residues at the NTD-CTD interface, d) various
interfacial salt-bridges distance.
Once the hydrophobic interactions begin to be disrupted, the SASA increases
rapidly and the rest of the hydrophobic interactions are disrupted. This allows the
domains to further separate, and additional hydrogen bonds are broken (region B in
Figure 4.3b). Separation of the domains becomes easier, the SASA increases and the
D56-K256 and E76-K291 salt-bridges in the interface are fully broken by 8 ns. This
sequence of bond disruption is consistent with the work of Bhaskara (113) and
Waldburger (114) who emphasize the importance of hydrophobic interactions in
stabilizing proteins. The NTD residues 72, 74, 95, 97, 125, 132, 156, 161, 162, 186, 187,
189, 191 and the CTD residues 283-286, 288-290, 293, 295, 317, 322, 323 form a strong
hydrophobic interface. As shown in Figure 4.4a, at 0 ns the interface is tightly packed and
provides little access to water, By 4 ns (Figure 4.4b), the domains have begun to separate
and gaps open at the hydrophobic interface, exposing SASA as quantified in Figure 4.3c.
The SASA averaged over seven different trajectories in Figure S3 (111) also shows the
same general trend.
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Figure 4.4 Hydrophobic residues at the domain-domain interface. (a) Initial closed-form.
(b) After the domains begin to separate (~4 ns), gaps open at the hydrophobic interface,
exposing SASA as quantified in Figure 4.3c.
After 8 ns, the few remaining interdomain hydrogen bonds are broken (BàC in
Figure 4.3b). Though the domains are always connected by the linker segment, after 10
ns, the only other interaction between the domains is the D45-K326 salt-bridge. Residue
K326 is at the end of the flexible tail of the CTD. As the CTD separates from the NTD,
this salt-bridge remains fully intact and acts as a connecting latch until 20 ns (region D in
Figure 4.3b) as displayed in Figure 4.2. I will show later that the extended latch-like D45K326 salt-bridge facilitates association of the separated domains into the closed-form
structure.

4.3 Salt-bridges and the interdomain stability
In order to understand the role of specific interaction in stabilizing the closedform structure, I mutated several important residues and pulled the CTD until the CTD is
disengaged from the NTD. Figure 4.5 shows for different mutants, the force necessary to
pull the CTD away from the NTD at constant speed. Since I was only interested in
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interdomain interactions, I pulled the CTD at a speed of 5 Å/ns for 4 ns and stopped after
the interface begins to open. For each mutant, 10 similar runs were performed and the
average force profile was calculated and displayed in Figure 4.5a. Although the
differences are small, the force profile for the WT generally shows more resistance to
pulling compared to the mutants. The K291E mutation removes the 76-291 salt-bridge
that is present in the WT, and as seen in Figure 4.5a, results in less force required to
separate the domains. This shows that the K291 salt-bridge is important in stabilizing the
closed-form structure. The comparison of hydrogen bonds in the WT and K291E as a
function of time during SMD is displayed in Figure 4.5b. The number of hydrogen bonds
is reduced by half in the initial state of the mutant, also weakening the domain-domain
interactions and contributing to the destabilization of the closed-form structure.
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Figure 4.5 (a) Force required for separating the CTD away from the NTD at constant
speed for the WT and different mutants. (b) The K291E mutation prevents formation of
the 76-291 salt-bridge and also decreases the number of interdomain hydrogen bonds,
further destabilizing the closed-form structure.
The D312R mutation removes the R148-D312 salt-bridge found in the WT.
Removal of the 148-312 salt-bridge weakens the domain interface and reduces the force
necessary to separate the domains (Figure 4.5a) compared to the WT. Another saltbridge, D56-K256, is buried and is not a major contributor to interdomain stability (114).
Upon alanine mutation K256A, which removes this salt-bridge, there is little change
compared to the WT in the amount of force necessary to separate the domains, as shown
in Figure 4.5a.
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4.4 VP40 mutant cellular localization analysis
The effects of some mutations in the salt-bridge network were assessed in live
HEK293 cells using an established EGFP-tagged VP40 system (115). The mutants
assessed included D45K, R148A, E160A, and K291E, which should abrogate the
aforementioned salt-bridges, as well as a control K90A. Lys90 was not shown to
participate in interdomain salt-bridges and previously was shown to form virus like
particles (VLPs) and localize to the plasma membrane inner leaflet, similar to WT
VP40(116) in CHO-K1 cells. EGFP-VP40 localized to the PM with characteristic high
intensity membrane protrusions (Figure 4.6a) (115), (116). Further quantification using a
MATLAB script revealed that K291E increased the %PM localization of VP40 by ~20%
(P<0.07) compared to the WT (Figure 4.6). These results suggest that removing the 76291 salt-bridge may alter the time scale of VP40 structural transitions but without
impairing the important interdomain associative forces likely provided by other saltbridge and hydrophobic interactions. The D45K had a similar PM localization as K291E.
It is important to note that the p-value for these measurements was >0.05. Because these
experiments are done at high concentrations of VP40 at a significant timeframe posttransfection, time-dependent assays may be needed to detect the time dependent changes
of the VP40 assembly to better assess the statistical significance of each mutation on
plasma membrane localization and oligomerization.
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Figure 4.6 Cellular localization and VLP analysis of interdomain NTD-CTD salt-bridge
mutants. (a) Representative images of VP40-EGFP constructs imaged 18-24 hours post
transfection into HEK293 cells. All images were acquired with a zoom of 8.0, therefore
the frame size is 20 µm and equivalent for all images. (b) Average plasma membrane
localization for each construct. Image analysis was performed in MATLAB to determine
the %PM localization for each. Error bars are ± the standard error of the mean. At least
28 cells were imaged per construct over three independent experiments on three different
days. (c) Representative blots of VP40 and respective mutations in VLPs (top panel) or
cell lysates (middle panel) or GADPH from cell lysates (bottom panel). (d) WT-VP40
VLP formation was set at 1 and each mutant was compared to WT-VP40 as fraction a of
VLP formation. The bars represent the averages ± standard errors of the means for three
independent experiments quantified using ImageJ. P-values for mutations were 0.002 for
D45K, 0.001 for R148A, and 0.004 for E160A. K90A and K291E P-values were not
statistically significant.
R148A or E160A did not contribute significantly to changes in PM localization.
As R148-D312 was the first salt-bridge to break in the domain separation simulation,
R148 likely plays a lesser role in mediating domain separation. As expected, K90A
appeared similar to WT and exhibited plasma membrane localization albeit slightly less
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than WT. As a whole, this live cell mutational analysis illustrates the differential
functions of salt-bridge networks in VP40 conformational regulation and opens the door
to large-scale cellular and in vitro analysis of VP40 conformational dynamics.
PM localization alone is not necessarily indicative of the oligomerization state of
VP40 where hexamers and larger oligomers have been detected (117), (115), (118),
(116). Thus, I monitored VP40 oligomerization state of EGFP-VP40 and respective
mutations using N&B analysis as previously reported (117), (115), (118), (116). EGFPVP40 and all mutations employed exhibited a similar extent of oligomerization (111) 1824 hours after transfection suggesting mutations still permit assembly of VP40 in some
fashion. However, the extent and type of oligomerization is difficult to discern with this
technique, as N&B measures the size of oligomers based upon the assembly of each
additional EGFP containing monomer. Thus, N&B is not able to decipher between a
VP40 filament that provides the structure for viral egress and a filament that may be
slightly twisted or less rigid based upon salt-bridge changes.
To determine if any of the VP40 salt-bridge mutations identified here influenced
VLP formation, I measured VLP formation for WT and respective mutations using a
VP40 antibody. VLPs were collected and measured 48 hours post-transfection using cell
lysate expression of VP40 and GAPDH (total protein/cell content) as a control for each
construct. Notably, several salt-bridge mutations had a statistically significant effect on
VLP formation. D45K, R148A, and E160A all reduced VLP formation while K291E had
a similar amount of VLPs as WT VP40. K90A showed a slight reduction in VLP
formation but statistical analysis demonstrated this reduction was not statistically
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significant.

Thus, despite a similar level of PM localization and oligomerization,

disruption of the D45-K326, R148-D312, or E160-K212 salt-bridges reduced VLP
formation suggesting these interactions have an important role in formation of VP40
structural assemblies that mediate efficient VLP formation. Notably, previous mutation
of K212 reduced VLP formation (119) by ~40%, further supporting the conclusions in
this study.

4.5 The Role of Salt-Bridges in Domain association
The various functions of VP40 require that the NTD and CTD domains be able to
exist in both a closed, associated form as well as an open, dissociated form. In both the
closed and open forms, a flexible segment consisting of residues 187-201 links the
domains (120). In general, multidomain proteins fold to the functional states by
association of already folded domains (121). The rate-limiting step for the complete
folding is often the correct matching of the domains at the interface, similar to proteinprotein association of structured proteins that is generally “diffusion-limited” (122),
(123), (124), (125). Dissociated domains that are connected only with a flexible linker
will have both rotational and translational degrees of conformational freedom and the
linker flexibility provides a large entropic barrier for correct interface matching. VP40
seems to have reduced this problem by introducing a second interdomain interaction to
guide the domain association by using a handshake-like latch interaction of the CTD tail
with a NTD flexible segment via the D45-K326 salt-bridge. The flexible nature of both
the long CTD tail ending in K326 and the unstructured NTD segment containing the
residue D45 increases the probability that these residues will interact in the open-form of
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VP40 and form a salt-bridge. This interdomain salt-bridge handshake, along with the
linker segment, reduces the number of possible relative orientations of the two domains
as they approach and provides specificity for domain association. This increases the
probability for a productive encounter that results in successful association of the CTD
and the NTD. This is akin to the binding mechanism of flexible, structurally disordered
proteins.(126),(127),(128) The contact of the CTD tail section with a loop in the NTD is
stabilized by both the D45-K326 salt-bridge as well as hydrophobic interactions between
the CTD-tail amino acids and amino acids in the NTD loop.
The initial structure for the association runs, displayed in Figure 4.7a was taken
from a frame in the SMD dissociation simulation in which the domains were separated.
This dissociated structure contained the latch-like CTD (tail)-NTD (loop) hydrophobic
interactions and the D45-K326 salt-bridge as shown in Figure S2. Even with the intact
latch-like interaction, the timescales for domain association may still be greater than
microseconds. In order to achieve domain association in a reasonable computational time,
the initial separated structure was carefully chosen so that the residues in the flexible
linker segment were minimally perturbed. Furthermore, only the 15 residues in the linker
segment (residues 187-201) and the last seven residues (320-326) in the CTD tail were
allowed to be fully flexible and all other residues in both domains were harmonically
restrained.

Figure 4.7b displays the final frame of the association run at 100 ns, along

with the superimposed native structure of the closed-form as a reference to display the
good similarity. The associated structure was within 2.6Å rmsd compared to the native
structure. The time course of the distance dcm between the center-of-mass (cm) of the
NTD and the cm of the CTD in Figure 4.7c gives the approximate time of association. At
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approximately 12 ns, the distance is ~25 Å, which is the NTD(cm)-CTD(cm) distance in
the WT VP40.

Figure 4.7 (a) Initial structure of the open-form of the VP40 used in the association MD
simulations. (b) The final closed-formed structure at the end of the 100-ns association
simulation, along with the PDB structure of the closed-form for reference. (c) Separation
between the NTD center of mass (cm) and the CTD cm. The horizontal line at
approximately 25Å represents the cm separation in the WT. (d) Time course of the
separation between the amino acids that make each of the three important salt-bridges
during domain-domain association.
I investigated the role played by the three salt-bridges that I found to be especially
important in domain association or in stabilizing the closed-form: R148-D312, E76-K291
and D45-K326. Figure S4 (109) shows that initially in the dissociated form, only the
D45-K326 salt-bridge is intact to guide the early stages of association. During the
association, the D45-K326 salt-bridge is broken, but the E76-K291 and R148-D312 saltbridges have formed to finalize association and stabilize the closed-form structure.
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More detailed information of the time course of these three salt-bridges is given in
Figure 4.7d. The D45-K326 salt-bridge provides initial specificity for association when
the domains are fully separated and starting to approach each other. This D45-K326 saltbridge breaks at 4 ns, which from Figure 4.7a is at a stage in which the domains are
almost in contact, but still separated by 4Å compared to the fully associated
conformation. At this stage, the domains are close enough that the other two salt-bridges,
E76-K291 and R148-D312, have already started to form. These two salt-bridges are
critical for guiding the domains during the middle stage of the association process after
the D45-K326 salt-bridge has broken, but before short range interdomain interactions are
active. For the CTD, I computed the average Cα rmsf when the latch with the D45-K326
salt-bridge was intact, and compared it to the rmsf of the CTD in when the latch is
broken. As can be seen in Figure S5 (111), the rmsf values of the CTD residues that are at
the domain interface are smaller and therefore the CTD is more constrained when the
CTD tail makes the salt-bridge with the NTD loop.
The importance of other interactions in the association process was studied by
comparing the SASA during dissociation and association as displayed in Figure S6 (ref.
(111)). The SASA during the association begins to significantly drop around 8 ns, which
is well after the D45-K326 guiding salt-bridge has broken. At 8 ns, the domains are very
near each other but not yet fully associated. Therefore, as expected for the short-range
hydrophobic interactions, they are helpful for guiding the final stages of association and
are important for stabilizing the closed-form structure. The guidance from hydrogen
bonds and hydrophobic interactions only at the latter stages of association highlights the
importance of salt-bridges in the early and intermediate stages of the association process.

74

5. THE VP40 DIMER AND HEXAMER INTERACTIONS WITH THE PM
5.1 Association of VP40 Dimer with the PM
A recent study revealed that the binding of the human antibody HuScFv inhibited
egress of Ebola VLPs from mammalian cells. One of the predicted interfaces between the
antibodies and eVP40 was the shorter helix (H1) (residues 265-272) in the c-terminal
domain (CTD) (129), suggesting that the shorter helix H1 plays a critical role in the
Ebola virus life cycle. Investigations on other systems have shown that helices can
mediate interactions between a protein and a membrane. Prakash et. al. (130) performed
AAMD simulations that showed that the oncogenic mutant K-Ras interacts with anionic
lipids with a preferred helix orientation that was parallel to the PM. Another study
pointed out the important role of a CTD α-helix in the binding of the heterodimer actincapping protein (CP) to a membrane (131). Combined molecular dynamics and
experimental studies (132) on the peripheral membrane protein Osh4 in yeast
Saccharomyces cerevisiae revealed a membrane binding region, an amphipathic lipid
packing sensor (ALPS)-like motif consisting of a helix, with a major role in stabilizing
the protein membrane interactions. In this work, I sought to understand the role of helix
H1 and other residues in the binding of the eVP40 dimer with the PM using all-atom
molecular dynamics (AAMD) simulations. To elucidate the atomic-level details of the
association mechanism of eVP40 with the plasma membrane, I performed simulations
with membranes consisting of different combinations of POPS, PI(4,5)P2 (i.e. PIP2), and
POPI lipids. I found that lysine residues in loop regions of the dimer play an important
role in the association process and interact with select lipids in the PM. The eVP40 dimer
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easily associated with a PM consisting of anionic lipids POPS, POPI, and PIP2. Our
results also showed that after the initial association, the H1 α-helix that is in contact with
the membrane can reorient itself so that it is aligned parallel to the PM. This parallel
orientation can then facilitate oligomerization into hexamers that can change the shape of
the membrane. In contrast, for a membrane without POPS, POPI, or PIP2, the dimer is
only transiently attached to the PM and in an orientation that does not encourage
hexamerization.
Figure 5.1 below illustrates the eVP40 dimer. Residues that have been
experimentally suggested as important for interactions with the PM (K224, K225, K270,
K274, K275) are colored in blue. The CTD helix H1 on each monomer consisting of
residues 265-272 is colored in red and I investigated its alignment with respect to the
membrane. In addition to these residues, our MD study revealed that polar residues
colored in green and lysine residues K221 and K236 are also important in the formation
of the eVP40-PM complex. Chemical interventions that perturb the above mentioned
orientation of the eVP40 dimer relative to the PM might disrupt VLP formation.
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Figure 5.1 The eVP40 dimer with the H1 helices on each monomer highlighted in red.
Lysine residues that are important in associating with the PM are colored in blue and
important polar residues are colored in green.
For the POPS/POPI and the POPS/PIP2 systems, the MD results agree with the
previous experimental result (12) that suggested the strong electrostatic interactions
between the positively charged lysine residues of the eVP40 dimer and negatively
charged head groups of the PM are the major force in binding the eVP40 dimer to the
PM. Figure 5.2 below displays snapshots of the time evolution of the systems. Figure 5.2
shows the initial and configurations of the dimer relative to the membrane for membrane
systems a) POPS/POPI b) POPS/PIP2 and c) no POPS/POPI/PIP2. Initially, the eVP40
dimer was placed ~10Å below the lower leaflet of the PM so that at t=0 ns there are only
weak interactions between the protein and the membrane. Figure 5.2a and 5.2b shows the
orientation of the dimer when it has associated with the membranes containing
POPS/POPI and POPS/PIP2 respectively. Supplemental movie S1 (148) shows the dimer
approaching and associating with the membrane. Important lysine residues on the dimer
and important POPS and POPI lipid molecules in the membrane are highlighted, and
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discussed below. In contrast, Figure 5.2c shows the orientation of the dimer when it has
weakly associated with the membrane containing no POPS/POPI/PIP2. Supplemental
movie S2 (148) shows the dimer approaching the membrane with no POPS/POPI/PIP2
and weakly associating at one end in the configuration depicted in Figure 5.2c.

Figure 5.2 MD Snapshots of the eVP40 dimer and plasma membrane show the initial and
final configurations of the dimer relative to the membrane for membrane systems a)
POPS/POPI b) POPS/PIP2 and c) no POPS/POPI/PIP2
5.1.1 eVP40-PM association kinetics
In order to investigate the atomic-level details of the association process, I
calculated the time dependence of two different parameters as displayed in Figure 5.3 that
provide information on the approach of the dimer towards the membrane. The parameter
dcm represents the separation distance between the center-of-mass (cm) of the dimer and
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the membrane. The Cα atoms in eVP40 were used to calculate the cm of the dimer, and
the phosphorous (P) atoms in the lower leaflet of the PM were used to calculate the cm of
the membrane. Initially, dcm ~40Å, which is equivalent to a separation of ~10Å between
the membrane and the nearest atoms of the dimer. For the systems with membranes
containing POPS/POPI or POPS/PIP2, dcm decreased by approximately 10Å during the
first 20 ns of the MD simulation as the dimer approached the membrane. Once the dimer
associated with the membrane in the orientation shown in Figure 5.2a and 5.2b, dcm
remained stable at ~30Å. In contrast, the system containing the membrane without
POPS/POPI/PIP2 had a dcm that never decreased. The orientation of the dimer shown in
Figure 5.2c requires the dimer to rotate significantly compared to its original orientation.
This rotation occurs over 60ns and moves the cm of the dimer farther from the
membrane, which explains why dcm increases for this system. Similar, timescales are
displayed in Figure 5.3b, which shows small-scale rearrangement of atoms in the dimer
due to interactions with the membrane. Figure 5.3b shows the root-mean-squaredifference (rmsd) in position, compared to their initial position after minimization,
averaged over all Cα in the dimer, as a function of time. The protein rmsd is calculated
with rotations and translations subtracted out. For the systems with membranes
containing POPS/POPI or POPS/PIP2, the rmsd underwent major changes in the first 20
ns. For the system with the membrane without POPS/POPI/PIP2, the rmsd changed more
gradually and stabilized after 60 ns.
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Figure 5.3. MD timescales for association of the eVP40 dimer with the plasma
membrane. a) The parameter dcm represents the separation distance between the centerof-mass of the Cα atoms in eVP40 and the P atoms in the lower leaflet of the PM. b) For
the dimer, the rmsd averaged over all Cα as a function of time. Translations and rotations
of the dimer are subtracted out.
The association of the dimer with the membrane involves interactions of lysine
residues in the loop segments with specific lipids in the PM. I discuss the details of these
interactions in the next section. After that section, I discuss additional binding involving
the H1 helix, which occurs on longer time-scales. The information on the H1 helix reorientation discussed later is derived from an 850 ns simulation that I performed on the
system with POPS/POPI.

5.1.2 eVP40-PM interactions
As hypothesized experimentally (12), I found that the association of the eVP40
dimer with the PM was dominated by electrostatic interactions. The initial docking was
primarily due to the interaction of positively charged lysine residues in the CTD loop
regions with the anionic heads of POPS, POPI, and PIP2 lipids in the membrane. This is
followed by the interaction of other residues in the CTD with the membrane. The number
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of hydrogen bonds between eVP40 and the PM as a function of time are plotted in Figure
5.4. For the strongly associating POPS/POPI and POPS/PIP2 systems, during the first 20
ns there was a sharp increase in the number of hydrogen bonds. The weakly associating
no POPS/PIPI/PIP2 system makes few hydrogen bonds. Our results on the proteinmembrane bonding are consistent with the work on the peripheral membrane protein
Osh4 in yeast Saccharomyces cerevisiae that showed hydrogen bonded interactions
between protein and anionic lipids POPS/POPI stabilized the protein membrane complex.

Figure 5.4. The time evolution of the number of hydrogen bonds between the eVP40
dimer and the PM.
There is strong electrostatic binding of the dimer with the membrane for the
systems with POPS/POPI and POPS/PIP2. The attractive interaction energy between the
protein and PM is almost two-fold stronger when the dimer is associated with the
membrane containing POPS/PIP2 compared to when the dimer is associated with the
POPS/POPI membrane. In the absence of these anionic lipids (system without
POPS/POPI/PIP2), the system displays very little interaction energy, which implies that

81

the dimer is barely associated with the membrane. The selectivity of the dimer for
interacting with POPS, POPI, or PIP2 lipid molecules is explored in the next section.

5.1.3 Protein-lipid selectivity
Figure 5.5 displays the selectivity of the eVP40 dimer for different lipid types.
Specifically, Figure 5.5 depicts the number of heavy atoms of lipids within 3.5 Å of any
atom of the eVP40 dimer. The number of contact of POPS lipid atoms with the eVP40
dimer in Figure 5.5b increases as the eVP40 dimer approaches the PM in the system with
POPS/POPI. The increase is sharp during the first 20 ns as the dimer approaches the
membrane, and then increases more slowly until 100 ns as the dimer undergoes smallscale structural rearrangements in loop segments and helix H1. This agrees with the
experimental result that eVP40 selectively binds with the POPS lipids in the PM (133)
(109), (118), (115). In the absence of anionic lipids (no POPS/POPI/PIP2), there was little
selectivity of lipid molecules, as shown in Figure 5.5a. The eVP40 dimer displays the
highest preference for the highly negatively-charged (-4) PIP2 molecules, as shown in
Figure 5.5c. The strong contacts between the dimer and PIP2 molecules reduce the
number of contact with other lipids such as POPS. This is consistent with the
experimental work of Johnson et al. (118) which highlighted PIP2 lipids that are crucial
for eVP40 oligomerization, and also consistent with our coarse-grained MD study that
observed enhanced selectivity of the dimer for PIP2 lipids in the presence of a VP40
hexamer (134). Similarly, MD studies (135), (136) on membrane interactions of the
auxilin-1 Phosphatase and Tensin Homolog (PTEN) have reported nanoclustering of PIP2
lipids, which enhances the binding of auxilin to the lipid bilayer.
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Figure 5.5 The number of heavy atoms in molecules of different lipid atoms within 3.5Å
of the dimer for different membranes. a) Without POPS/POPI/PIP2, b) With POPS/POPI,
c) with POPS/PIP2. Color scheme: blue-POPC, magenta-POPE, cyan-PSM, yellow-CHL.
I found that flexible loop regions of the dimer that contain positively charged
lysine residues were especially important for interacting with the anionic POPS, POPI, or
PIP2 molecules. This is shown in Figure 5.6, which is a snapshot from the MD simulation
with the POPS/PIP2 membrane. Figure 5.6 shows that flexible loop regions in each
monomer that contain positively charged lysine residues make strong contacts with
regions of the membrane containing high concentrations of PIP2 molecules. The
dynamics of these flexible loop regions are investigated in the next section.
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Figure 5.6 A snapshot from the MD simulation with the POPS/PIP2 membrane showing
that loop regions (orange) in the dimer that contain positively charged lysine residues
interact strongly with negatively charged PIP2 molecules (blue).
5.2 Conformational changes in the VP40 Dimer due to the PM Binding
To further understand the eVP40-PM association dynamics and complex stability,
I continued our simulation system with POPS/POPI until 850ns. I explored the dynamics
of the loop residues in the eVP40 dimer when interacting with the PM. The two loops are
labelled as Loop-1 and Loop-2 as shown in Figure 5.7a. Loop-1 consists of residues 219233 and includes two important lysine residues, K224 and K225.

Loop-2 includes

residues 274-283 and contains two important lysine residues, K274 and K275.
Experimental studies found that deletion of these loop residues hindered VLP formation
(12). Our MD investigations studied the difference in the flexibility of these loops during
the dimer-PM association.
The positively charged lysine residues on Loop-1 and Loop-2 interact with
negatively charged POPS and POPI molecules in the membrane. Despite the relatively
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small fraction of POPS and POPI in the membrane (26%, Table S2), the eVP40 dimer
manages to increase the probability of occurrence of favorable interactions between the
protein and the membrane. During the initial association process in the first 50 ns, the
rmsf is much larger than at later times. Therefore, as the dimer approaches the PM, the
loops are flexible enough to allow lysine residues some freedom to be attracted to anionic
lipid molecules. As shown in Figure 5.7b and 5.7c, the rmsf of the Cα atoms of the CTDs
of chain A and chain B decrease after they interact with the PM. Thus, once the dimer is
in contact with the PM, the loops regions become relatively fixed in place, which helps to
maintain strong interactions of the dimer in the membrane.

Figure 5.7 a) Two important loop regions in the eVP40 dimer that contain lysine residues
that interact with the PM (Loop-1, residues 219-233 and Loop-2, residues 274-283) b)
RMSF of the Cα atoms of the CTDs of the eVP40 dimer; the higher dashed bar
represents Loop-1, and the shorter represents Loop-2.
5.3 Orientation of CTD helices in VP40 Dimer
The eVP40 dimer has an α-helix (H1) in each CTD (colored red in Figure 5.1)
that can interact with the PM. Investigations on other systems have shown that helices
can mediate interactions between a protein and a membrane (130), (131), (132). Here, I
investigated the behavior of the eVP40 dimer’s helices upon membrane association.

85

In the 850 ns simulation trajectory of the POPS/POPI system, I monitored the
orientation of the H1 helices in each CTD of the dimer. The orientation of a helix with
respect to the membrane is given by the tilt-angle ψ. The tilt-angle ψ is calculated as
ψ≡(90 - q), where the complimentary angle q is the angle between the normal of the
PM’s lower leaflet and the vector along the helix. A parallel orientation of the helix with
respect to the inner leaflet of the membrane would have ψ=0. Figure 5.8a displays frames
with the CTD helices (colored red) in various orientations. Figure 5.8b shows that over a
period of 850 ns, the H1 helices in both Chain A and Chain B reorient themselves to
approach a parallel orientation.

Figure 5.8 Orientation of the CTD helices (red) with respect to the membrane. a) MD
frames showing the helices in various orientations at different times. b) Helix-tilt angle
for the helix relative to the membrane. During the 850 ns MD simulation, helices in both
Chain A and Chain B reorient themselves to approach an orientation parallel to the
membrane.
The helix H1 consists of residues T266, L267, V268, H269, K270, L271 and
T272. In examining later MD frames with ψ~10o, I found that an H1 parallel orientation
allowed stronger interactions between POPS and POPI lipids in the membrane and polar

86

residues T266, H269, T272 and charged residue K270, as shown in Figure 5.9. As the
helix approaches a parallel orientation at later times, the number of bonds, especially for
K270 increases. This rearrangement of the helix is a conformational change of the eVP40
dimer that further stabilizes the eVP40-PM complex in an orientation that facilitates
subsequent hexamerization.

Figure 5.9 a) When helix H1 is aligned parallel to the membrane at later times, residues
T266, H269, K270, can interact strongly with anionic membrane lipids POPS and POPI.
b) The time evolution of the number of hydrogen bonds formed between T266, H269,
K270 and membrane lipids.
5.4 The hydrophobic residue V276 inserts into a membrane defect
Our MD studies also showed a possible mechanism for membrane penetration of
amino acids in the dimer. The electrostatic interactions between cationic protein residues
and lipid polar/charged groups can create membrane defects that allow insertion of
hydrophobic residues into the hydrophobic inner region of the membrane and increase the
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binding. There is evidence for this in other systems. Lai et al. (137) proposed that
electrostatic interactions between the GRP1 PH domain and lipids on the membrane were
crucial to the stabilization of the equilibrium membrane binding structure of the PH
domain. Their findings suggested that arginine and lysine residues (R277, K279)
interacting with the charged phosphate groups on the membrane surface created transient
lipid defects that allowed a hydrophobic residue (V278) to insert into the bilayer head
group region and helped to bind the PH domain. The same effect was seen in combined
MD and experimental studies of the binding of RecA protein at the surface of anionic
membranes (138).
In our eVP40 dimer system, the hydrophobic residue V276 is close to the
positively charged lysine residues K274 and K275 that strongly interact with the
membrane. In our simulations, I observed that the electrostatic interactions between these
lysine residues and the charged heads of the anionic POPS and POPI lipids created
transient membrane defects which allowed the hydrophobic residue V276 to partially
insert into the hydrophobic inner region of the membrane. These interactions might add
extra stability to the protein membrane complex. Figure 5.10 illustrates a small
membrane defect created by lysine residues and a partial penetration of V276 inside the
membrane.
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Figure 5.10 The hydrophobic V276 residue can partially penetrate the membrane at a
small membrane defect created by lysine residues interacting with POPS and POPI
molecules.
5.5 Clustering of PIP2 Lipids in the Lower Leaflet of the PM
5.5.1 Hexamer and PM model
The initial x-ray crystal structure of the VP40 hexamer was taken from the protein
data bank (PDB) [PDB entry 4ldd]. The hexamer is formed by three dimers that join via
their N-terminal domain (NTD) interfaces. The C-terminal domains (CTD) of VP40 at
the two ends are intact but the other four CTDs are missing in the crystal structure. Based
on the orientations of the dimers in the hexameric structure2, two of the middle CTDs
point towards and interact with the membrane, whereas the other two CTDs point
towards the cytoplasm. The missing CTDs that interact with the membrane were inserted
using Modeller (139). These CTDs were oriented in such a way that the hydrophobic
residues that are known to penetrate the membrane face towards the membrane (36),
(117).
The membrane-VP40 hexamer system was generated using the Charmm-GUI (71) web
server. An asymmetric lipid bilayer was generated in accordance with the high
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complexity of the plasma membrane composition (140), (141). The percentage of various
lipids

(POPC:POPE:PSM:POPS:PIP2:CHOL)

in

the

modeled

membrane

were

(41:8:23:4:4:20) in the outer (or upper) leaflet and (11: 37: 5: 16: 10: 21) in the inner (or
lower) leaflet. The lipid-bilayer is generated large enough to accommodate the hexamer.
The solvated membrane-protein system contained >600,000 atoms in the all-atom
representations, but in the coarse-grained set up, the numbers were significantly reduced
as described below. The lipid bilayer without protein was composed with the same ratios
of the phospholipid mixture as described above for the bilayer with protein.
In order to investigate the VP40-membrane interactions, I prepared the hexamermembrane system with the middle two CTDs facing the lower leaflet of the membrane so
that the hydrophobic residues Leu213, Ile293, Leu295, and Val298 in a loop region were
in direct contact with the membrane, as predicted by experiments (36), (117). The allatom as well as coarse-grained representations of the system are displayed in Figure 5.11.
The all-atom representation in Figure 5.11a includes the lower CTDs that interact with
VP35 proteins that are involved in packaging and incorporating the viral RNA into VLP
(142). As they do not influence the membrane binding, the lower CTDs were not
included in the CGMD simulations (Figure 5.11b) to further reduce computational time.
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Figure 5.11 VP40 hexamer-membrane system. a) All-atom representation of VP40
hexamer at the PM lower-leaflet, side view. b) Coarse-grained representation, side view
c) Distribution of various lipids in the initial setup, as viewed from the bottom. Lipids are
colored as Light-Blue: PIP2, Green: POPC, White: POPE, Gray: PSM, Pink: POPS,
Purple: CHOL.
I performed a 10-µs CGMD simulation and monitored the dynamics of the VP40
hexamer-membrane interactions. The initial setup has several amino acids in the middle
two CTDs interacting with the membrane. The protein center-of-mass was initially set
approximately 54 Å below the membrane, measured from the z-coordinate of the center
of mass of the lipid bilayer. During the MD simulations, the protein diffuses laterally
around the lower leaflet and also increases the protein-membrane contacts. After ~ 3 µs,
the CTDs at the two ends interact more strongly with the membrane. Figure 5.12a shows
the relative distance between the lipid and protein center of masses (zcm) as a function of
time. As the two CTDs at the end start to interact strongly with the membrane, zcm is
significantly reduced.
In Figure 5.12b, I display the number of each type of lipid near the VP40 hexamer
as a function of time. The normalized count for a lipid type is calculated as the number of
that lipid type within 7Å of the protein divided by the total number of that lipid type in
the lower leaflet of the PM.

Interestingly, PIP2 is the only lipid type that shows

significant crowding around the protein. The normalized count for PIP2 increases steadily
until ~3 µs and plateaus to a much larger value (~25%) than the normalized counts of the
other lipid types (<10%). It is worth noting that the reduction in zcm in Figure 5.12a
occurs after the occurrence in Figure 5.12b of significant PIP2 crowding around the
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protein. I further investigated the crowding of PIP2 by exploring the lipid clustering in the
membrane with or without protein, as discussed below.
Figure 5.12c shows a noticeable bulging or bending in the PM. This is because an
increase in the number of contacts between the membrane and the end-CTDs cause the
hydrophobic residues Leu213, Ile293, Leu295, and Val298 to penetrate further into the
membrane.

Figure 5.12 a) distance between the lipid and protein center of masses (zcm), b)
Normalized count of various lipids within 7Å of the VP40 hexamer as a function of time,
c) Bending (or bulging) of the membrane due to enhanced lipid-protein interactions.
5.5.2 Lipid Clustering in the PM With and Without VP40 Hexamer
Different types of mammalian cell plasma membranes have different lipid
compositions and the differences in lipid compositions can affect how proteins interact
with the membranes (143). Through coarse-grained MD simulations, it has been shown
that certain lipid types tend to cluster in the membrane (68). Especially important, the
local lipid composition caused by clustering was found to directly affect the membrane
curvature (68). Since membrane bending is important for VLP formation, I investigated
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changes in the local lipid composition due to lipid clustering in the presence of the
protein.
I investigated the distribution of PIP2 in the lower leaflet of the plasma membrane
in the presence of the VP40 hexamer and compared it with the distribution of PIP2
without the protein. The top panel of Figure 5.13a, displays the VP40 hexamermembrane systems as viewed from below (cytoplasmic side) at different times. The
bottom panel of Figure 5.13a displays the same system as in the top panel but with the
protein removed to better show the lipid distribution in the membrane. In the beginning
(0 µs), the PIP2 lipids are randomly distributed (as generated by Charmm-GUI). By 3 µs,
a significant clustering of PIP2 is observed, mostly in the periphery of the protein.
Besides PIP2, no other lipid type showed such clustering behavior. To compare the
behavior of the lipids in the absence of protein, I performed a 10 µs simulation with only
the membrane and display the results in Figure 5.13b. Initially (0 µs), the PIP2 lipids are
randomly distributed as in Figure 5.13a. By the end of the 10 µs simulation, PIP2 shows
some clustering but to a significantly lesser extent compared to the clustering in the
presence of the protein (Figure 5.13a).
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Figure 5.13 Distribution of lipids (PIP2: Green) in the lower leaflet of the PM. a) Results
of the CGMD simulation with the presence of the VP40 hexamer. The top row shows the
VP40 hexamer (Yellow), the row below are the same snapshots with the VP40 hexamer
removed so that the lipids are visible. b) Results of the CGMD simulation in the absence
of a protein.
Upon closer inspection of the PIP2 clusters in the periphery of the protein, I
observed that the PIP2 head groups interact strongly with the basic and polar residues in
VP40 as shown in Figure 5.14a. Since some of the CTD residues penetrate the
membrane, the locations of the CTDs are noticeable in Figure 5.14b as gray areas
surrounded by PIP2 lipids (green). I calculated the radial pair distribution function g(r) for
the various lipid types relative to the VP40 hexamer. The g(r) quantifies the relative
abundance of a specific lipid type around the protein. As shown in Figure 5.14c, PIP2
molecules significantly cluster around the protein, compared to other lipid types. Lipid
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types POPE, POPS and CHOL show only a weak preference to be in contact with the
protein, and POPC seems to have the least preference.

Figure 5.14 Distribution and clustering of PIP2 lipids a) Distribution of the PIP2 lipids
near the VP40 hexamer at 0 µs and 5 µs showing the negatively charged lipid head
groups interacting with the positively charged or polar residues on the protein. b)
Clustering of PIP2 lipids due to VP40. The VP40 was present in the simulation but is
removed from the image to allow full view of the membrane. PIP2 molecules cluster
around gray regions that are the location of the VP40 CTDs. c) Radial pair distribution
functions for various lipid types relative to the VP40 hexamer.
5.5.3 Quantification of Lipid Clustering
To quantitatively compare the distribution and clustering of the lipid molecules
with and without VP40, I calculated the fractional interaction matrix (68) for the lipids in
the lower leaflet of the PM. The fractional interaction matrix, also known as the
preferential partitioning of membrane components represents the normalized number of
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contacts with a specific lipid type and has been used to study lipid phase separation into
ordered and disordered domains in various bilayer systems containing peripheral and
transmembrane proteins (144), as well as phase separations (69) and lipid clustering and
membrane curvature in various bilayer systems (68). The fractional interaction matrix is
calculated as
pij =

j][ /l[

(5.5.3.1)

` j]` /l`

Here, the preferential partitioning pij represents the number of contacts of the lipid type i
relative to the lipid type j, normalized over the number of all lipid contacts with the lipid
type i. The number of contacts cij is calculated based on the distance between the
glycerol ester moiety (GL1/GL2 beads) of POPE, POPC, POPS, PIP2 or amino alcohols
(AM1/AM2 beads) of PSM or cholesterol ROH.
Figure 5.15a displays the fractional interaction matrix for the five different types
of lipids in the lower leaflet of the bilayer at 10 µs in the presence of the VP40 hexamer.
Two lipids are counted as being in contact if they are within 11 Å, which includes both
the first and second solvation shells. The fractional interactions of each lipid type with all
lipid types are given in the rows, and the values are normalized horizontally. If all five
lipid types are randomly distributed, the entries would be 0.20. The fractional interaction
for PIP2 with itself (first entry, Row 5) is found to be 0.40, which means that about 40%
of the PIP2 contacts are with PIP2 itself and represents clustering. The fractional
interactions for any other lipid type (Rows 1-4) are approximately 0.20, indicating
randomly distributed lipid contacts. This means that lipid types such as POPE, POPC and
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PSM each have about the same probability to be in contact with themselves or with other
lipid types. POPS is found to have the least preference to be surrounded by PIP2.
To assess any enhancement in lipid clustering due to the VP40 hexamer, I
compared the fractional interaction matrices for bilayers systems with and without the
protein. Figure 5.15b displays the fractional interaction matrix for the lipids in the lower
leaflet of the membrane-only bilayer system in the absence of VP40. In the absence of the
protein, the PIP2-PIP2 fractional contact is 0.30, compared to 0.40 Figure 5.15a in the
presence of protein. This suggests that the presence of the VP40 hexamer enhances the
PIP2 clustering by 33%. Such enhancement in PIP2 clustering by VP40 can be
functionally important in the viral life-cycle since local clustering of PIP2 in the lower
leaflet has been shown to result in curvature of the membrane (68).

Figure 5.15 Fractional interaction matrix of lipids in the lower leaflet of the plasma
membrane. a) With the VP40 hexamer. b) Without the VP40 hexamer.
5.5.4 Mechanism of Lipid Clustering
PIP2-PIP2 clustering can occur in the plasma membrane due to formation of
hydrogen bond networks (145) with water molecules and/or Ca2+ that balance the
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electrostatic repulsion between negatively charged head groups (146). I explored the
molecular details of the PIP2 interactions leading to PIP2 clustering around VP40 and
found that the repulsion between negatively charged phosphate head groups (P1 or P2
beads) can be balanced by the electrostatic attraction mediated by positively charged
protein side chains (SC2 bead of Lys and Arg). Figure 5.16a shows a network of
alternating Lys-PIP2 interactions. When a cationic side chain mediates two PIP2 head
groups from either side as shown in Figure 5.16b, cholesterol molecules are found to fill
the space thus created. This also explains why PIP2 has higher self-clustering in the
second solvation layer. I calculated the radial pair distribution of PIP2 against all other
lipid types and found that cholesterol is the most abundant lipid type around PIP2,
followed by POPE. This is reflected in Figure 5.16c by the high radial pair distribution
for PIP2-CHOL. In addition to cholesterol, PIP2 is also significantly surrounded by
POPE, due partly to the high percentage of POPE in the membrane, giving a high radial
pair distribution for PIP2-POPE (Figure 5.16c). This also helps in forming a higher PIP2PIP2 distribution in the second solvation layer.
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Figure 5.16 Illustration of the role of lysine residues in PIP2 clustering. a) The network of
interacting Lys and PIP2. b) Lysine side chains mediating PIP2-PIP2 interactions c)
Radial pair distribution function of other lipids around PIP2 lipids

6. CONCLUSIONS
I performed molecular dynamics simulations to investigate the molecular and
atomic level dynamics of large-scale structural changes in transformer proteins. I focused
my investigations on RfaH and Ebola VP40. I first studied the mechanisms of the all-α to
all-β conformational changes in the RfaH-CTD. In order to facilitate a faster structural
conversion, I used an implicit solvent EEF1 force-field with the replica exchange
molecular dynamics (REMD) technique. I explored the free-energy landscape of the
conformational space of the RfaH-CTD that spanned the α-helix and β-configurations. I
used detailed all-atom simulations to refine the structure of the replica which is closest to
the experimentally observed RfaH-CTD β-structure. I analyzed the time evolution during
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the all-α to all-β transformation of various structural parameters such as rmsd, number of
H-bonds, and secondary structure formation. The early onset of the loss of helicity of the
CTD Helix I as compared to Helix II in the absence of the NTD sheds light on the
importance of interfacial interactions between the two domains of RfaH. Results suggest
that the folding into the β-scaffold proceeds with formation of an antiparallel β-hairpin
structure. Through information transfer entropy calculations, I identified major driverresponder residues that are involved in helix unfolding as well as β-scaffold folding.
Future investigations of the RfaH-CTD with detailed all-atom simulations for all steps in
the α-helix to β-structural conversion process will allow a better understanding of the
dynamics of this transformer protein, which may serve as a good model system for
investigating protein structural transformations in general.
I continued my research to a full RfaH molecule and investigated the mechanisms
of the structural transformation of the CTD in the full RfaH using various molecular
dynamics techniques. Through dynamic network analysis, I determined the communities
of amino acids that are involved in interdomain and intradomain communications.
Examination of these communities showed that amino acid F126 in the CTD shows
correlated motions with the NTD amino acids I93, S97, and L96. F126 also affects the
RNAP binding site through interaction with I93, making it a possible functionally
relevant residue.
Using targeted MD, I investigated the aàb as well as the bàa structural
transformation of the CTD in the full RfaH. The observed folding and unfolding
pathways are different for the forward and back conversions. The observed mechanism
for the folding of the CTD into the b-barrel structure is consistent with those from
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previous computational studies of the isolated CTD. In the presence of the NTD,
however, the CTD helix unfolding process leading to the initiation of the b-structure is
different. Instead of going through a completely unfolded random coil state, the a-helix
to b-structure transition occurs through a collapsed globular state in which significant
residual hydrophobic interactions are present. Also, the order of the unfolding of the CTD
helices is reversed due to interactions with the NTD. I used the Adaptive Biasing Force
method to calculate the free-energy profile for the structural transformation. I find that
the CTD-NTD interdomain interactions constitute the main barrier in the CTD α-helix to
β-barrel structural conversion. Once the interfacial interactions are broken, the structural
conversion of the CTD is relatively easy. SMD calculations elucidated specific amino
acids at the interdomain coupling between movement of the CTD helices and the NTD
helix, and show how solvent accessible surface area is affected at the RNAP binding site.
Using various molecular dynamics simulations, I investigated the dynamics of the
association and the dissociation processes of the NTD and CTD domains in the Ebola
virus VP40 transformer protein. MD simulations reveal a novel interdomain salt-bridge
interaction between D45-K326 as part of the NTD-CTD latch that was shown to be
important for regulating VP40 oligomerization. The results suggest that the salt-bridge
interaction between D45-K326 is helpful in guiding domain-domain association, whereas
the E76-K291 interaction stabilizes the closed-form structure. VLP analysis demonstrated
that some of these salt-bridges may be significant in forming the correct VP40 assembly
structure for significant scission and VLP formation. For instance, mutation of the D45K326, R148-D312, and E160-K212 salt-bridges led to a statistically significant reduction
in VLPs. Live cell imaging using an EGFP-tagged VP40 system revealed that the
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mutation K291E shows an enhanced PM localization. This may be because the K291E
mutation that abrogates the salt-bridge allows easier domain dissociation, which is an
important step in VP40 hexamerization at the plasma membrane leading to VLP
formation. These computational and experimental live cell mutational analyses illustrate
the differential functions of salt-bridge networks in VP40 conformational regulation and
open the door to large-scale molecular, membrane, cellular and in vitro analysis, and
computational studies of VP40 conformational dynamics. Further experiments are
necessary to investigate the time-dependency of plasma membrane localization and the
biophysics of assembly of VP40. For instance, VP40 localization, trafficking and
oligomerization may need to be studied from initial stages of VP40 protein expression to
scission of mature VLPs detectable at early stages of infection.
I also investigated the Ebola virus protein VP40 dimer interactions at the lower
leaflet of the PM for different lipid compositions of the membrane. For the POPS/POPI
and the POPS/PIP2 systems, the strong electrostatic interactions between the positivelycharged lysine residues of the eVP40 dimer and negatively-charged head groups of the
PM are found to be the major driving force in binding the eVP40 dimer to the PM.
During association with a membrane containing anionic POPS, POPI, or PIP2, several
different lysine residues in loop regions of the dimer interact with the anionic lipid
molecules in the membrane. Subsequent to the initial association, CTD helices of the
dimer reorient to add additional stabilizing interactions. The helix orientation that most
enhanced the binding is when H1 helix is aligned parallel to the PM. This alignment of
helix H1 allows electrostatic interactions between lysine K270 as well as polar residues
H269, T272, T266 of the protein with the anionic lipids of the membrane.
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Our MD simulations revealed an additional stabilizing effect due to penetration of
the hydrophobic residues into the PM. The lysine residues can interact with anionic lipid
molecules to create defects in the membrane and these defects allow hydrophobic
residues such as V276 to partially insert into the membrane. The bound eVP40membrane complex with partial insertion of hydrophobic residues into the membrane not
only provides dimer stability but may also affect the lateral diffusion (137), (147) of the
dimer at the PM. Our investigations provide a molecular level detail of the eVP40 dimer
localizations at the lower leaflet of the PM and understanding these lipid-protein
interactions can be helpful in designing chemical interventions that disrupt VLP
formation.
To investigate the protein-lipid interactions for the Ebola virus protein VP40
hexamer at the lower leaflet of the plasma membrane, I used CGMD simulations. The
PIP2 lipid is found to have a tendency to cluster in general, but this clustering is
significantly enhanced in the presence of the VP40 hexamer. PIP2 was found to cluster
around two CTDs of the VP40 hexamer. Each CTD has a hydrophobic loop that
penetrates the membrane bilayer and lies adjacent to a cationic patch rich in Lys residues.
It is found that the electrostatic interactions of negatively charged PIP2 head groups with
cationic Lys side chains mediate the PIP2 clustering, with cholesterol filling the space
between the PIP2s. The overall mechanism is consistent with the hypothesis that PIP2
stabilizes VP40 oligomers (118). PIP2 is likely important for the initial association of
VP40 to the plasma membrane bilayer, including formation of VP40 hexamers and larger
oligomers from VP40 dimers (115). PIP2 then becomes exposed on the plasma membrane
outer leaflet as VP40 accumulates on the inner leaflet through a yet to be determined
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mechanism (115). Clustering of PIP2 would provide a mechanism to further concentrate
VP40 oligomers and stabilize the underlying VP40 matrix layer, and to promote viral
budding by causing membrane bending. Further biophysical investigation is warranted to
determine if and how VP40 induces PIP2 clustering in vitro and in cells, how PIP2
contributes to membrane bending, and if cholesterol distribution in the plasma membrane
affects VP40 assembly and budding. These studies may also prove useful in determining
pharmacological strategies for inhibiting budding of the Ebola virus from the plasma
membrane. For instance, therapeutic agents that can modulate membrane curvature or
alter membrane fluidity in such a way to reduce plasma membrane bending may be
sufficient to slow down the spread of the virus.

Overall Summary
Moonlighting proteins uses their same fold to perform two or more distinct biophysical or
biochemical functions (Jefferry, 2015, J of Proteomics, 2009 , molecular biosystems). On
the other hand, Metamorphic proteins possess structural plasticity from the same
sequence of amino acid residues (Murzin, Biochemistry). Recently, a newly class of
proteins is defined as “Transformer proteins” that carries the properties of moonlighting
and metamorphic proteins and can undergo conformational change to perform different
functions (Knauer, 2012, cell cycle). These proteins are rare in nature and some examples
are transcription factor RfaH and Ebola virus protein VP40 (Bornholdt, 2013, GC 2015,
2016). The Carboxy-terminal domain of RfaH (RfaH-CTD) folds and refolds from all-a
to all-b form to carryout different functions. However, the homolog NusG has
structurally similar NTDs and possess 17% sequence identity on both domains has only
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all-b form of CTD. The all-a form of RfaH-CTD masks the binding site of RNAP and
inhibits the transcription process. The all-a form transform into all-b form after it is
activated by the OPS element of ntDNA. The all-b form of RfaH-CTD enhances the
translation by recruiting S10 ribosomes. Another example of a transformer protein is the
Ebola virus protein VP40, which exists in different conformations depending on the
required function: a butterfly shaped dimer is trafficked to the lower leaflet of the
membrane, a hexamer to form the viral matrix, and an octamer ring structure to bind to
RNA and regulate viral transcription.
The structural conversions in these transformer proteins are interesting from the
protein folding point of view. Instead of a single native state and a unique function, these
proteins have different native states with different functions which deviates from the
common principle of protein folding. These proteins are also important in designing
molecular switch that can be used as biosensors or smart Biomaterials used in biology,
biomedicine and biotechnology (Ha and Loh , Chemistry, 2012).
I investigated the structural conversion in transformer proteins, transcription
factor RfaH and Ebola virus protein VP40 using molecular dynamics simulations.
Experiments (Burmann et. al) suggested that the expression of RfaH-CTD alone will
spontaneously refold from all-a to all-b form. Using replica exchange MD (REMD), I
investigated the all-a to all-b structural change in RfaH-CTD in isolated form. During
REMD simulations of isolated RfaH-CTD, the structural integrity of shorter helix H1 was
compromised and was unfolded faster compared to longer helix H2. The residues in the
H1 were responders in the helix unfolding and were quantified using transfer entropy.
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The formation of b-barrel structure were driven by residues in b3 and b4 hairpins that
were formed first in the nucleation process. After investigating the molecular details of
the structural conversion isolated RfaH-CTD, I performed simulations on full length
RfaH where I used targeted MD simulations, Steered MD simulations (SMD) to
understand the structural change of RfaH-CTD in the presence of tertiary contact with the
NTD of RfaH. The NTD-CTD interdomain interactions was observed as a major barrier
in the structural change of RfaH-CTD. Once the barrier is broken, the all-a to all-b of
RfaH-CTD was found to be easier. Using SMD, I highlighted the interdomain saltbridge
between E48-R138 as a major interaction. These results support the experiments (Burman
et. al 2012) that the E48S mutant was readily detached from the NTD and was converted
to b-barrel structure.
In the mean time when I was investigating a Transformer protein RfaH, there was
an Ebola outbreak that caused many deaths and surprisingly one of the proteins in Ebola
virus is a Transformer protein. The Ebola virus protein VP40 exists in different
conformations depending on the required function: a butterfly shaped dimer is trafficked
to the lower leaflet of the membrane, a hexamer to form the viral matrix, and an octamer
ring structure to bind to RNA and regulate viral transcription. The common structural
change in these pathways is the domain rearrangement which is VP40’s transformer
properties. I performed simulations to understand the domain rearrangement of Ebola
VP40 monomer and highlighted important saltbridges in the interdomain region. The
D45-K326 saltbridge was observed to be important in the domain dissociation and
association. The force profiles showed mutants required less force to separate domains.
Experiments performed showed a 20% increase in the plasma membrane localization of
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mutant K291E which was due to easy detachment of the domain required for the
formation of oligomers in the plasma membrane.
Ebola virus is a lipid-enveloped virus. As the virus enters the human cell, it
hijacks the host cell machinery and replicate itself. Once the protein VP40 is encoded by
its negative sense ssRNA, VP40 convert into dimer and is trafficked in the lower leaflet
of the plasma membrane. Three dimers assemble in the membrane and undergo
membrane rearrangement to form a hexamer. I performed simulation on the VP40 dimer
and membrane systems and observed the electrostatic interaction as a major driving force
in the association kinetics. The positive charged lysine residues in the VP40 dimer was
found interacting with the negatively charged anionic lipids such as POPI, POPS and
PIP2. In the absence of these anionic lipids, VP40 dimer was associated weakly with the
membrane. In addition to the electrostatic interaction, the additional stability of the
protein-membrane complex was found to be due to the helix H1 alignment parallel to the
lower leaflet for the membrane. This alignment allowed the efficient hydrogen bonded
interactions between the protein and the membrane. I also observed a slight insertion of
hydrophobic residues V276 inside the hydrophobic core of the membrane which might be
important in the diffusion kinetics of VP40.
Finally, I investigated the VP40 hexamer and plasma membrane interactions
using coarse grained MD (CGMD) simulations. Experiments performed by Johnson et al.
highlighted the role of PIP2 lipids in the oligomerization of VP40. Since POPS lipids was
found exposed to the outer leaflet of the plasma membrane at the budding site, PIP2 lipids
are important at the interaction site of VP40 oligomers and the membrane. A
computational study by Koldso et. al. on the unrelated membrane system showed a
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correlation between the membrane curvature and the enrichment of PIP2 lipids in the
lower leaflet of the plasma membrane. This resulted in the membrane bending with
concave upward. I performed CGMD on hexamer and membrane system and observed
the enhanced clustering of PIP2 lipids in the lower leaflet of the plasma membrane. This
clustering helped in a slight bulging of the membrane at the interaction site. There is a
general tendency of PIP2 lipids to self-cluster, but I observed the 30% increase in the
clustering of PIP2 due to the VP40 hexamer. The radial pair distribution function of PIP2
lipids is greater near the VP40 hexamer. I observed an extensive ionic interaction
between the SC2 bead of lysine residues in the VP40 hexamer and P2 beads of PIP2 lipids
and the void between lipids is filled with the cholesterol.
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